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Background: Vitamin D is now recognised as having a role in in immune system functioning and in 
protection against several complications of pregnancy and common diseases of childhood. In 2012, a 
Consensus Statement was released by the New Zealand Ministry of Health that described the 
populations who are at risk of deficiency, how to manage vitamin D status whilst being conscious of 
the harsher ultraviolet environment in New Zealand and outlined who may benefit from vitamin D 
supplementation. Furthermore in 2013, a Companion Statement was released which provided 
additional information about vitamin D specific to the pregnant, lactating and infant populations. 
These documents were designed primarily for use by health professionals. There is limited literature 
available that explores health professionals’ knowledge of vitamin D in New Zealand. International 
literature is conflicting with some studies reporting good knowledge of vitamin D deficiency risk 
factors, sun exposure guidelines and supplement guidelines while others report limited knowledge in 
these areas. International studies have reported on health professionals’ knowledge of vitamin D 
supplement guidelines for infants with conflicting results. Identifying areas where knowledge is lacking 
will help to identify where New Zealand health professionals require further education.  
 
Aims: The aim of this study is to explore health professionals’ knowledge, attitudes and current 
practices toward vitamin D for the general population, pregnancy and infancy. Furthermore, this study 
aims to explore whether knowledge and attitudes have changed between 2010 and 2019. 
 
Methods: In this ecological study, an anonymous online questionnaire was used to collect data from 
health professionals working in a profession recognised by the Health Practitioners Competence 
Assurance Act. Professionals working with pregnant women, infants and their caregivers were sought 
after in particular. This questionnaire was conducted in 2010 and in 2019 with different sample 
populations. Questions were developed in 2010 and in line with available New Zealand guidelines that 
detailed management of vitamin D status. These were the Food and Nutrition Guidelines for Healthy 
Infants and Toddlers and for Healthy Pregnant and Breastfeeding Women, and the Cancer Society 
Position Statement on the Risks and Benefits of Sun Exposure. Question types were a combination of 
multiple response sets and true or false and yes or no response options. Knowledge questions were 
forced response to avoid missing data whereas participant characteristic questions were request 
response to respect privacy. Descriptive statistics were used to analyse the results.  
 
Results: A total of 283 HPCAA-recognised health professionals completed this questionnaire (2010 
n=193; 2019 n=90). Health professionals have good knowledge of vitamin D sources, functions and 
risk factors for deficiency. There appears to be confusion surrounding the vitamin D content of 
breastmilk (44.4% in 2010 and 31.5% in 2019 selected breastmilk as a good dietary source of vitamin 
D) and exclusive breastfeeding as a risk factor for deficiency (selected by 14.6% in 2010 and 32.9% in 
2019). Knowledge of sun exposure guidelines was challenging to ascertain but results indicated a lack 
of awareness of safe sun exposure guidelines, primarily for infants. Furthermore, participants from 
both years were largely unsure about vitamin D supplement availability. Majority of participants did 
not feel there was enough information available to health professionals regarding vitamin D (81.2% in 
2010; 74.4% 2019).  
 
Conclusion: Whilst health professionals had good knowledge of deficiency risk factors, functions and 
sources of vitamin D, the study identified some knowledge deficits. Interventions to improve 
knowledge are likely to be well received as majority of participants believe there is not enough 
information available to health professionals about vitamin D. Areas where health professionals need 
further education are the vitamin D content of breastmilk, recognition of exclusive breastfeeding as a 
deficiency risk factor in infants, supplement availability and sun exposure guidelines.  
 iii 
Further studies that explore where health professionals’ source their information from regarding 
vitamin D may provide insight as to why these gaps in knowledge have occurred and how to best 
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Chapter 1. Introduction 
 
1.1 Background 
The discovery of vitamin D was somewhat backwards in that the implications of deficiency where 
identified first when British physicians published works detailing the bone disease now known as 
rickets (Holick, 2006). Over time, researchers began to acknowledge the relationship between sun 
exposure, ultraviolet radiation (UVR) and bone health after rickets was found to be more prevalent in 
areas of high pollution (Holick, 2006).   
 
More than a century later, the vitamin itself was recognised when biochemist Elmer McCollum treated 
rachitic rats with an oxidised cod liver oil (Holick, 2006). Following this, a key accomplishment in 
vitamin D research was contributed by Harry Steenbok. The biochemist identified that foodstuffs 
reacted to UVR and this finding was used as a basis for the food fortification procedures that helped 
to eradicate rickets around Europe and The United States in the 1940s (Holick, 2006). 
 
Cutaneous vitamin D synthesis is the main source of vitamin D in counties with ample sunshine such 
as Australia and New Zealand (Nowson et al., 2012). Dietary sources of the vitamin are limited; these 
include oily fish or fish oils, offal, meat, eggs and dairy (Shrapnel & Truswell, 2006). Foods fortified 
with vitamin D provide an additional dietary source however at present, fortification with vitamin D is 
a voluntary process in New Zealand. Fortification is restricted to margarine and edible oils and certain 
dairy foods including infant formula (Food Standards Australia New Zealand, 2017; Shrapnel & 
Truswell, 2006). Internationally, stricter fortification policies have been associated with higher intakes 
of the vitamin (Shrapnel & Truswell, 2006). Vitamin D supplements are also available both on 
prescription and over the counter.  
 
The most recognised function of vitamin D relates to the skeletal system as the vitamin has an 
endocrine function in bone mineral homeostasis by regulating serum concentrations of calcium and 
phosphate (Pike & Christakos, 2017). More recently however, research has turned toward the 
potential immunomodulatory role of vitamin D. This follows studies in rachitic children that identified 
an association between the bone disease and respiratory tract infections (Yakoob, Salam, Khan, & 
Bhutta, 2016). Following discovery of vitamin D receptor (VDR) expression in several tissues involved 
with immune system functioning, it is believed that the vitamin influences both the innate and 
adaptive immune systems (Wei & Christakos, 2015).  
 
In the New Zealand context, vitamin D deficiency is defined as serum 25-hydroxyvitamin D (25(OH)D) 
at 24nmol/L or below; insufficiency is defined as 49nmol/L or below (Ministry of Health and Cancer 
Society of New Zealand, 2012). Clinical manifestations of deficiency include delayed growth, delayed 
standing and walking, and frequent falling in children (Bordelon, Ghetu, & Langan, 2009; Thacher & 
Clarke, 2011; van Schoor & Lips, 2018). In adults it may present as bone pain, fractures, and muscle 
weakness (Bordelon et al., 2009; Thacher & Clarke, 2011; van Schoor & Lips, 2018). New Zealand-
based studies have identified vitamin D deficiency and insufficiency in several age brackets (Bolland 
et al., 2006; Camargo et al., 2010; Grant, Wall, Crengle, & Scragg, 2009; Houghton et al., 2010; Lucas 




Given UVR is the primary source of vitamin D, risk factors for deficiency are based largely on 
inadequate exposure to UVR (Nowson et al., 2012). Certain populations who are at risk of this include 
those who are housebound, institutionalised or regularly spend large amounts of daylight hours inside 
(Nowson et al., 2012). Inhabitants of New Zealand are exposed to greater amounts of UVR due to 
comparatively minimal amounts of air pollution and depletion of ozone (Pondicherry et al., 2018). 
Despite this, vitamin D deficiency is well-documented in this nation. Because of the high UVR, New 
Zealand holds one of the highest rates of skin cancer in the world (Pondicherry et al., 2018). It has 
been hypothesised that beliefs about skin cancer risk and subsequent sun exposure practices may 
contribute to vitamin D deficiency (Youl, Janda, & Kimlin, 2009).  The literature is conflicting however, 
with many who report concern about skin cancer risk, not applying regular sunscreen (von Hurst, 
Stonehouse, & Coad, 2010; Walker et al., 2014). Furthermore, sunscreen use has been associated with 
higher serum levels of vitamin D as sunscreen use is typically associated with greater time spent 
outdoors (Fayet-Moore et al., 2019). Concealing clothing worn for both sun protective and religious 
reasons has been associated with poor vitamin D status however (Springbett, Buglass, & Young, 2010). 
Additionally, ethnicity influences vitamin D status as those with darker skin tones are less able to 
cutaneously synthesise vitamin D as effectively (Webb et al., 2018). This is secondary to the melanin 
pigment in skin competing with 7-dehydrocholesterol (7-DHC) for UVR photons (Webb et al., 2018). 
Particularly relevant to the New Zealand population is latitude. This is a proposed risk factor for 
deficiency as locations at higher latitudes are exposed to lesser amounts of UVR due to the earth being 
further away from the sun (Godar, 2005). For the same reason, season is a risk factor in the colder 
months of May to August. The effect of latitude on vitamin D status of New Zealanders is conflicting 
however when combined with the effect of season, the effect appears stronger (Ministry of Health, 
2012).   
 
Pregnant women are at greater risk of deficiency as maternal vitamin D stores are responsible for 
provision of vitamin D to the developing fetus. Maternal vitamin D metabolism is upregulated to 
support the increased requirements (Pludowski et al., 2013; Wheeler et al., 2018). Vitamin D 
insufficiency has been assessed in the New Zealand population of pregnant women. Wheeler et al. 
reported 25(OH)D levels below 50nmol/L in 65% of the 80 pregnant participants (Wheeler et al., 2018). 
Ekeroma et al. reported 25(OH)D levels below 50nmol/L in 109 of the 259 pregnant participants 
(Ekeroma et al., 2015). In a sample population of 2800 pregnant women from Australia and New 
Zealand, 772 women were identified as having 25(OH)D levels below 50nmol/L (Wilson et al., 2018). 
A recent Cochrane review has suggested that vitamin D supplementation during pregnancy may have 
a protective role against the development of several pregnancy complications including pre-
eclampsia, gestational diabetes (GDM) and birthing an infant who is small for gestational age (SGA) 
(Palacios, Kostiuk, & Peña‐Rosas, 2019). There is evidence to support a link between maternal vitamin 
D status and pre-term birth (PTB) however the results were not supported in the Cochrane review 
(Palacios et al., 2019). New Zealand does not incorporate these potential outcomes into 
supplementation guidelines at present, as the research is conflicting and the mechanisms linking 
vitamin D to the aetiology of these conditions remains unclear (Ministry of Health, 2013a). 
Furthermore, PHARMAC does not currently fund a vitamin D supplement designed specifically for 
pregnant women (Best Practice Advocacy Centre New Zealand, 2011). These women however may be 
prescribed vitamin D supplements as per preparations available through PHARMAC for the general 




Vitamin D insufficiency and deficiency has been explored in the New Zealand population of infants 
and toddlers. A study of 925 healthy new-borns identified cord blood 25(OH)D levels below 25nmol/L 
in one out of five participants. An additional 57% of participants had 25(OH)D levels below 50nmol/L 
(Camargo et al., 2010). Additionally, a study of 55 infants and toddlers between the ages of 12 and 22 
months who had blood samples taken in winter, reported that 78% had 25(OH)D levels below 
50nmol/L (Houghton et al., 2010).  Grant et al. reported that 25(OH)D levels below 27.5nmol/L were 
identified in 46 of the 353 participants between the ages of six and 23 months (Grant et al., 2009). 
Similar to pregnant women, infants have additional risk factors for vitamin D deficiency compared to 
the general population. These include maternal vitamin D deficiency and pre-term birth secondary to 
the infant’s dependence on maternal stores to develop their own (Rigo & Senterre, 2006). Further risk 
factors are exclusive breastfeeding and limited sun exposure (Ministry of Health, 2013a). New Zealand 
guidelines recommend that infants who are not independently mobile are not exposed to direct 
sunlight at any time of the day (Ministry of Health, 2013a). This is secondary to the immaturity of their 
skin which carries increased susceptibility to damage by UVR (Shafie Pour, Saeedi, Morteza Semnani, 
& Akbari, 2015); during this time, infants are more reliant on dietary source of vitamin D. Breastmilk 
is not a rich source of the vitamin (Wheeler, Dickson, Houghton, Ward, & Taylor, 2015). Research 
suggests, however, that breastmilk may be a good source of vitamin D when the mother is 
supplemented with a daily dose of vitamin D. Hollis et al. reported that daily maternal 
supplementation with 6400IU of vitamin D safely increased the breastfed infants’ vitamin D status to 
the same extent as supplementing the infant with a daily dose of 400IU of vitamin D (Hollis et al., 
2015). Lovell et al. reported however that maternal vitamin D supplementation, dietary intake and 
sun exposure were not independently associated with vitamin D status of breastfed infants (Lovell, 
Wall, & Grant, 2016). This suggests that further evidence is required to support the role of maternal 
supplementation in improving the vitamin D concentration of breastmilk. Furthermore, this practice 
is not currently included in New Zealand guidelines (Ministry of Health, 2013a; Ministry of Health and 
Cancer Society of New Zealand, 2012). Breastmilk should therefore continue to be recognised as a 
poor source of vitamin D. 
 
In 2019, PHARMAC opted to fund an infant-specific vitamin D-only supplement (PHARMAC, 2018). 
Current New Zealand guidelines recommend administering supplements to infants and pregnant 
women prophylactically if they present with one or more risk factors for deficiency (Ministry of Health, 
2013a; Ministry of Health and Cancer Society of New Zealand, 2012). Despite this guideline, there is 
evidence of under-supplementation in the New Zealand paediatric population (Wheeler et al., 2015). 
As with pregnant women, there is a growing body of evidence which highlights extra-skeletal roles of 
vitamin D in infant health. It has been suggested that poor vitamin D status in infants has an 
association with asthma, respiratory tract infections, eczema and food allergies (Saggese et al., 2015). 
Further randomised controlled trials and subsequent meta-analyses are required to strengthen these 
findings as the results are currently conflicting (Saggese et al., 2015). The mechanisms by which 
vitamin D exerts these roles are unclear but thought to be immunomodulatory (Saggese et al., 2015).  
 
Health care professionals help to educate the population about vitamin D. Furthermore, health 
professionals are in a key position for identifying those who may be at risk of deficiency and 
subsequently managing vitamin D status. For this to be effective, health professionals must have 
adequate awareness of this topic and of the evidence-based guidelines devised for practitioners to 
utilise when discussing vitamin D with patients (Dix, Robinson, Bauer, & Wright, 2017). The guideline 
currently available in New Zealand is the 2012 New Zealand Consensus Statement on Vitamin D 
(Ministry of Health and Cancer Society of New Zealand, 2012). For pregnant women and infants, the 
Companion Statement to the 2012 New Zealand Consensus Statement on Vitamin D is more suitable 
(Ministry of Health, 2013a). These documents were released in 2012 and 2013 respectively; no further 
updates have been provided.  
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Additionally, a shared Australian and New Zealand Bone Mineral Society Position Statement exists 
pertaining to vitamin D in adult, pregnant women and infant health (Nowson et al., 2012; Paxton et 
al., 2013).  Prior to the release of these guidelines, information about vitamin D in relation to pregnant 
women and infants could be sourced from Food and Nutrition Guidelines for Healthy Infants and 
Toddlers (0-2): A Background Paper (Ministry of Health, 2008a) and Food and Nutrition Guidelines for 
Healthy Pregnant and Breastfeeding Women: A Background Paper (Ministry of Health, 2006a). A New 
Zealand-based study was conducted in 2010 that assessed GP’s knowledge of vitamin D (Reeder, 
Jopson, & Gray, 2012). The study reported moderate awareness of deficiency risk factors and 
confusion around sun exposure guidelines during winter for achieving vitamin D adequacy (Reeder et 
al., 2012).  To the authors knowledge, further research into the knowledge of New Zealand health 
professionals has not been conducted following the release of the Consensus and Companion 
Statements. Internationally, similar results have been observed with Australian dietitians and GPs 
lacking knowledge of sun exposure guidelines during winter (Bonevski et al., 2012; Dix et al., 2017). 
Furthermore, these studies identified that health professionals were advising unsafe sun exposure 
practices in summer (Bonevski et al., 2012; Dix et al., 2017). Health professionals’ knowledge of 
vitamin D for infancy and pregnancy has been explored internationally. Awareness of supplement 
guidelines were explored in American health professionals with conflicting results as the outcome. 
Oberhelman et al. reported that health professionals, in line with American Paediatric Association 
guidelines (APA), prescribed vitamin D supplements to exclusively breastfed infants 70% of the time, 
suggesting good awareness of the guideline (Oberhelman, Cozine, Umaretiya, Maxson, & Thacher, 
2018). DelGiudice et al., however, reported that health professionals were largely uncertain about 
vitamin D supplementation guidelines for patients aged 18 years or younger (DelGiudice et al., 2018). 
Similar to Oberhelman et al., AlBishi et al. reported that 77% of health professionals in their Saudi 
Arabia-based study prescribed vitamin D supplements to breastfed infants, as per APA guidelines, 
suggesting health professionals have good knowledge of the guidelines (AlBishi et al., 2018). Jain et 
al. reported that health professionals in their British study were uncertain about vitamin D 
supplementation guidelines for infants, pregnant, and breastfeeding women. Furthermore, health 
professionals reported uncertainty about supplementation guidelines for patients who are at high risk 
of deficiency (Jain, Raychaudhuri, & Barry, 2011). The aforementioned studies share similar 
limitations. Sample sizes are small, and the studies reference national guidelines not used in New 
Zealand. There is a gap therefore, in New Zealand literature relating to health professionals’ 
knowledge of vitamin D for pregnancy and infancy. 
 
1.2 Purpose of Study 
Outcomes of recent research have highlighted vitamin D’s involvement in immune system functioning, 
in prevention of complications of pregnancy and in prevention of common childhood diseases 
(Palacios et al., 2019; Yakoob et al., 2016). Continuing to assess knowledge of vitamin D in health care 
providers is therefore a justified research avenue, given the seriousness of vitamin D’s suggested roles. 
 
According to New Zealand guidelines, testing of serum vitamin D concentration is too costly for 
conducting on a national level. Guidelines therefore focus on prevention of vitamin D deficiency and 
identification of those who are most at risk (Ministry of Health and Cancer Society of New Zealand, 
2012). Evidence suggests that health professionals in Australia and New Zealand have a varied 
understanding of deficiency risk factors and sun exposure guidelines that are suitable for managing 
skin cancer risk whilst achieving vitamin D adequacy (Bonevski et al., 2012; Dix et al., 2017; Reeder et 
al., 2012; Reeder, Jopson, & Gray, 2013). Furthermore, this research is mostly limited to knowledge of 
GPs (Bonevski et al., 2012; Reeder et al., 2012) and does not extend to other professions who are likely 
to work with pregnant women and infants such as midwives and Plunket nurses. Lastly, this evidence 
is outdated as it was conducted prior to the release of the Consensus and Companion Statements.  
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To the authors knowledge, there is no New Zealand-based research that specifically assesses health 
professionals’ knowledge of vitamin D for pregnancy and infancy. Internationally, awareness of 
vitamin D supplement guidelines for infants has been explored with conflicting outcomes (AlBishi et 
al., 2018; DelGiudice et al., 2018; Jain et al., 2011; Oberhelman et al., 2018). American, Saudi-Arabian 
and British studies report uncertainty amongst health professionals regarding vitamin D 
supplementation guidelines for infants (AlBishi et al., 2018; DelGiudice et al., 2018; Jain et al., 2011). 
An American study reported good awareness of supplementation guidelines in health professionals, 
however (Oberhelman et al., 2018). These studies are limited by their small sample sizes and use of 
differing guidelines than those used in New Zealand. As such, this data cannot be extrapolated to the 
New Zealand population. New Zealand-based research is therefore needed.  
 
This study hopes to build on the understanding of health professional’s knowledge of vitamin D for 
the general population, pregnant women and infants. Results of this study may identify gaps in 
knowledge and thus can be used to identify where further education is needed for health 
professionals relating to vitamin D.  
 
1.3 Aim 
The aim of this study is to explore health professionals’ knowledge, attitudes and current practices 
toward vitamin D for the general population, pregnancy and infancy. Furthermore, this study aims to 
explore whether knowledge and attitudes have changed between 2010 and 2019. 
 
1.4 Objectives 
1. To assess changes in health professionals’ knowledge of vitamin D sources, functions and 
deficiency risk factors. 
2. To assess changes in health professionals’ knowledge and attitudes toward New Zealand sun 
exposure guidelines for vitamin D adequacy.  
3. To assess changes in health professionals’ awareness of vitamin D supplements in New 
Zealand for pregnancy and infancy. 
4. To explore changes in health professionals’ current practices when vitamin D deficiency is 
suspected in a pregnant or infant patient. 
 
1.5 Thesis Structure 
The first chapter of this thesis provides the background and purpose of this study. The aim and 
objectives of the study are also outlined here. Chapter two is comprised of a review of the literature. 
This review provides a more in-depth background to the study and covers key aspects of vitamin D 
physiology as well as guideline content for the general population, pregnancy and infancy. 
Furthermore, it reviews the available literature pertaining to health professionals’ knowledge of 
vitamin D. In chapter three is the research study manuscript. This chapter includes a full description 
of the methods employed and results obtained by this study. Chapter four provides a summary of the 
manuscript in that it provides a conclusion, an overview of the study’s contribution to current 
literature and recommendations for the use of this data. Located in the appendices are additional 
findings not discussed in chapter three, the documents required for the research’s approval and the 




1.6 Researcher’s Contributions 
 
Table 1.1 Researcher’s Contributions   
Researcher Contribution 
Alex Thomson 
Master of Science Nutrition and Dietetics 
Student 
Primary researcher and main contributor to 
2019 questionnaire process; completed ethics 
application and associated documents, 
conducted literature review, recruited 
questionnaire participants, completed data 
collection, entry and analysis, including analysis 
of 2010 data, prepared final manuscript. 
Associate Professor Pam von Hurst 
Academic Supervisor 
Main contributor to 2010 questionnaire 
process; review of literature, designed 
questionnaire, completed ethics application 
and associated documents, recruited 
questionnaire participants, completed data 
entry.  
 
Assisted with 2019 questionnaire recruitment, 
supervised manuscript development. 
Associate Professor Cath Conlon  
Academic Supervisor 
Main contributor to 2010 questionnaire 
process; review of literature, designed 
questionnaire, completed ethics application 
and associated documents, recruited 
questionnaire participants, completed data 
entry.  
 
Assisted with 2019 questionnaire recruitment, 
supervised manuscript development. 
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Chapter 2. Literature Review 
 
In this chapter is a review of the literature relating to vitamin D’s history, sources, physiology and 
roles in human health. Furthermore, it covers vitamin D in relation to pregnancy and infancy, and 
health professionals’ knowledge of this topic. PubMed and Google Scholar were used with search 
terms that had been determined based on the aims and objectives of this study. Filters were used to 
improve applicability of large search returns. The following filters were applied: past two years, past 
five years, past 10 years. Journal articles were used only if they were published in English and had 




AND insufficiency  
AND risk factors 
AND New Zealand 
AND supplementation 
AND pregnancy OR maternal 
AND infancy OR child 
AND healthcare professional OR healthcare practitioner OR health professional OR health 
practitioner 
AND knowledge  
AND attitude 
 
2.1 Brief History of Vitamin D:  
The journey of vitamin D’s discovery, unbeknownst to researchers at the time, dates back to the 1600s 
where Britain-born physicians Daniel Whislter and Francis Glisson published independent works that 
described one of the more serious outcomes of vitamin D deficiency, rickets (Holick, 2006; Norval, 
2005; O'riordan & Bijvoet, 2014; Wolf, 2004). Jędrzej Śniadecki, a Poland-born physician, provided the 
next publication that alluded to vitamin D. His work, published in the 1800s, identified a higher 
prevalence of rickets amongst children living in polluted areas of Warsaw and he attributed this to a 
lack of sun exposure (Holick, 2006; Norval, 2005; O'riordan & Bijvoet, 2014; Wolf, 2004). Śniadecki’s 
research, however, went largely unnoticed (Holick, 2006; Norval, 2005; O'riordan & Bijvoet, 2014; 
Wolf, 2004).    
 
Much later in the 1920s, paediatrician Kurt Huldschinsky hypothesised that artificial sunlight would be 
sufficient for treating rickets (DeLuca, 2014; Holick, 2006; Wierzbicka, Piotrowska, & Żmijewski, 2014; 
Wolf, 2004). Huldschinsky was able to confirm his hypothesis after exposing rachitic children to UVR 
emitted from mercury lamps. There was an improvement in their symptoms without any exposure to 
natural sunlight or use of supplements (DeLuca, 2014; Holick, 2006; Wierzbicka et al., 2014; Wolf, 
2004). Two years following this work, physicians Alfred Hess and L. J. Unger were able to alleviate 
symptoms of rickets in children by exposing them to sunlight (DeLuca, 2014; Holick, 2006; Wierzbicka 
et al., 2014; Wolf, 2004). Vitamin D as the key piece of this puzzle had not yet been alluded to.  
 
Another arm of vitamin D’s discovery was being undertaken by physician Sir Edward Mellanby circa 
1920 (DeLuca, 2014; Holick, 2006; Norval, 2005; Wierzbicka et al., 2014; Wolf, 2004). By this point, the 
scientific community had an understanding that trace elements within foods, namely vitamins A, B 
and C, were essential for human health. Captivated by this work, Mellanby suspected that, like 
xeropthalmia, beri beri and scurvy, rickets may be a disease that occurs due to a deficiency in the diet 
(DeLuca, 2014; Holick, 2006; Norval, 2005; Wierzbicka et al., 2014; Wolf, 2004). Mellanby went on to 
successfully treat rachitic Beagles with cod liver oil.  
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It was not until Elmer McCollum, a biochemist, repeated the experiment with rats however, that the 
antirachitic component was correctly determined. Mellanby attributed the antirachitic effect to the 
already-discovered vitamin A; McCollum however, following oxidation of the cod liver oil and thus 
degradation of its vitamin A content, concluded that a new vitamin was responsible (DeLuca, 2014; 
Holick, 2006; Norval, 2005; Wierzbicka et al., 2014; Wolf, 2004). This new vitamin was aptly named 
with the next available letter in the alphabet, vitamin D (DeLuca, 2014; Holick, 2006; Norval, 2005; 
Wierzbicka et al., 2014; Wolf, 2004).    
 
The research took a different direction when Harry Steenbok, a professor of biochemistry, discovered 
in 1924 that not only humans but foodstuffs reacted to UVR; irradiation of the food given to rachitic 
rats successfully alleviated their symptoms (DeLuca, 2014; Holick, 2006; Norval, 2005; Wierzbicka et 
al., 2014; Wolf, 2004). This work was extremely important in development of food fortification 
procedures that aided in the eradication of rickets in Europe and the United States by the 1940s 
(Holick, 2006).  
 
One of the final, key pieces of work in vitamin D’s discovery was identification of the differing vitamin 
D structures (DeLuca, 2014; Holick, 2006; Norval, 2005; Wierzbicka et al., 2014; Wolf, 2004). This 
research was led by German chemist Adolf Windaus and his research team in the 1930s (DeLuca, 2014; 
Holick, 2006; Norval, 2005; Wierzbicka et al., 2014; Wolf, 2004). In 1955, Harry Steenbok, previously 
mentioned for his contribution to the eradication of rickets, retired and handed his laboratory over to 
his graduate chemistry student Hector DeLuca (Wierzbicka et al., 2014). DeLuca later joined forces 
with Michael Holick, an endocrinologist; the pair contributed many advancements in the field of 
vitamin D research, both independently and collaboratively (Wierzbicka et al., 2014). DeLuca and 
Holick were pioneers in understanding vitamin D metabolism and they continue with this work today 
(Wierzbicka et al., 2014). 
 
2.2 Sources and Metabolism: 
There are two chemical forms of this fat-soluble vitamin; ergocalciferol or Vitamin D2 and 
cholecalciferol or Vitamin D3 (Gil, Plaza-Diaz, & Mesa, 2018; Holick, 2017; Tripkovic, Wilson, & Lanham‐
New, 2017). The two forms differ only by their sidechain structure; they share the same activation 
mechanism and prohormone activity (Gil et al., 2018).  
 
2.2.1 Radiation 
Both vitamin D2 and vitamin D3 can be synthesised via action of ultraviolet radiation (UV) (Gil et al., 
2018; Holick, 2007; Lehmann & Meurer, 2010; Tuckey, Cheng, & Slominski, 2018). This mechanism is 
the primary source of vitamin D3 for humans. In human skin, 7-DHC, otherwise known as pro-vitamin 
D3 and is predominantly located in the plasma membrane of cells within the epidermis layer, absorbs 
UV at wavelengths of 290-315nm and is converted to biologically inactive pre-calciferol, otherwise 
known as pre-vitamin D3 (Gil et al., 2018; Holick, 2007; Lehmann & Meurer, 2010; MacLaughlin, 
Anderson, & Holick, 1982; Tuckey et al., 2018; Wacker & Holick, 2013). Vitamin D intoxication from 
UV-stimulated synthesis is not possible. This is because prolonged exposure to UV causes pre-
calciferol to isomerise into lumisterol3 and tachysterol3, both of which are biologically inactive, or back 
to 7-DHC (Buckley, Hannoun, Lessan, Holick, & Barakat, 2017; Wacker & Holick, 2013).  
 
In a heat-dependent reaction, pre-calciferol isomerizes to cholecalciferol (Gil et al., 2018; Tian, Chen, 
Matsuoka, Wortsman, & Holick, 1993; Tuckey et al., 2018; Wacker & Holick, 2013). This change in 
structure causes cholecalciferol to be released from the plasma membrane where it was once 
incorporated in the phospholipid bilayer (Holick, 1988, 2003, 2008b). To enter the circulatory system, 
cholecalciferol diffuses from the epidermis layer to the dermal capillary bed and is carried to the liver 
bound to vitamin D binding protein (DPB) (Holick, 1988, 2008b; Osmancevic et al., 2015).  
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In a similar manner to vitamin D3 metabolism, ergosterol, a membrane-bound sterol otherwise known 
as provitamin D2, is converted to biologically inactive pre-ergocalciferol (pre-vitamin D2) which further 
isomerises to ergocalciferol (Gil et al., 2018; Jäpelt & Jakobsen, 2013; Keegan, Lu, Bogusz, Williams, & 
Holick, 2013).  Synthesis of vitamin D2 by radiation is not a metabolic function that humans are capable 
of but instead occurs in fungi. For this reason, humans are able to obtain vitamin D2 only from the 
diet.   
 
2.2.2 Dietary 
Although not the primary source for humans, vitamin D can be obtained from the diet in small 
amounts via a limited number of foods (Shrapnel & Truswell, 2006). Natural food sources of vitamin 
D2 are of plant-origin and primarily include members of the Kingdom Fungi, namely mushrooms and 
yeast. These foods however must undergo UV exposure in order for vitamin D2 to become utilisable 
for human metabolism (Hayes & Cashman, 2017; Keegan et al., 2013). Vitamin D3 is naturally present 
without need for radiation in oily fish and or fish oils, offal, meat, eggs and dairy (Holick, 2008b, 2017; 
Schmid & Walther, 2013; Tripkovic et al., 2017; Wilson, Tripkovic, Hart, & Lanham-New, 2017). There 
is concern that healthy eating guidelines both in New Zealand and around the world typically do not 
support an intake of dietary vitamin D that is sufficient to meet adequate intake reference ranges 
(Shrapnel & Baghurst, 2007; Shrapnel & Truswell, 2006). This is secondary to the guidelines supporting 
reduced dietary fat intakes as a means of preventing obesity and cardiovascular disease (Shrapnel & 
Truswell, 2006). The 2008/09 New Zealand Adult Nutrition Survey did not analyse dietary vitamin D 
intake as food composition data for this nutrient was deemed unreliable (Ministry of Health, 2011).  
 
The Nutrient Reference Values for Australia and New Zealand (NRVANZ) recommend a dietary intake 
of 5g per day as this figure safely accounts for minimal sunlight exposure (Ministry of Health, 2006b). 
There is variation in the vitamin D content of foods within each of the aforementioned, vitamin D-rich 
food groups which highlights the need for specificity when discussing dietary modifications to ensure 
adequate vitamin D intake (The New Zealand Institute for Plant and Food Rsearch Limited & The 
Ministry of Health, 2016). 
 
Dietary vitamin D2 and vitamin D3, are absorbed in the small intestine and arrive at the liver via 
transport in chylomicrons (Gil et al., 2018; Jäpelt & Jakobsen, 2013). 
 
2.2.3 Food Fortification  
In 1996, the New Zealand government permitted voluntary vitamin D fortification of margarine and 
edible oil spreads, as well as dairy foods including infant milk formulas but excluding full-fat milk (Food 
Standards Australia New Zealand, 2017). Infant formulas in New Zealand are required to contain 0.25-
0.63g of vitamin D per 100kJ (Grant et al., 2009). Fortification policies vary around the world; more 
wide-spread or mandated rather than voluntary fortification is associated with higher intakes of 
vitamin D (Calvo & Whiting, 2013; Cashman & Kiely, 2016; Itkonen, Erkkola, & Lamberg-Allardt, 2018; 
Nowson & Margerison, 2002; Nowson et al., 2012; Shrapnel & Truswell, 2006). Similarly to naturally 
occurring food sources of vitamin D, fortified foods are unable to provide adequate vitamin D to meet 
requirements when UVR is lacking (Green, Skeaff, & Rockell, 2010; Itkonen et al., 2018). In a 2010 
randomised controlled trial (RCT) with 73 New Zealand-based females, participants receiving fortified 
milk had significantly higher levels of vitamin D than the controls. This increase was unable to buffer 
the seasonal decline in vitamin D levels, however that occur secondary to changes in intensity of UVR 





Supplementation is effective in meeting vitamin D requirements when dietary intake and UVR is 
inadequate (Płudowski et al., 2013). Over-the-counter dietary vitamin D supplements are readily 
available to the New Zealand population. For groups at risk of deficiency however, part- or fully-
subsidised preparations are available with prescription.  The 2012 New Zealand Consensus Statement 
on Vitamin D and The Best Practice Advocacy Centre New Zealand (BPACNZ) recommend prescription 
of vitamin D supplements prophylactically to these at-risk groups without need for testing vitamin D 
status (Best Practice Advocacy Centre New Zealand, 2011; Ministry of Health and Cancer Society of 
New Zealand, 2012). These publications were released in 2012 and 2011 respectively. No further 
supplement guidelines have since been released in New Zealand. BPACNZ states that supplements 
should be prescribed when an at-risk individual is unable to increase their amount of direct sun 
exposure or increase their intake of dietary vitamin D. Furthermore, the 2012 New Zealand Consensus 
Statement advises that dietary vitamin D supplements that are non-PHARMAC-subsidised are not 
recommended. This is due to the unpredictability in manufacturing quality, variation of dose and 
safety of co-ingredients.  
 
2.2.5 Activation 
In the form of vitamin D2 or vitamin D3, the vitamin has little biological activity. Vitamin D2 and vitamin 
D3 must first undergo two hydroxylation reactions catalysed by enzymes from the cytochrome p450 
family (Bikle, 2016; Gil et al., 2018; Lips, 2006). In the liver, vitamin D is converted to 25(OH)D; the 
circulating and storage form of vitamin D (Gil et al., 2018; Jablonski & Chaplin, 2018).  25(OH)D bound 
to DPB arrives at the kidneys where it is converted to 1,25-hydroxyvitamin D (1,25(OH)2D) in the 
renal proximal tubules. It is in this form that vitamin D is biologically active and able to exert its 
hormone functions via stimulation of gene expression within target tissues (Gil et al., 2018; Jablonski 
& Chaplin, 2018). Tissues that require calcitriol express VDR, a nuclear receptor (Jablonski & Chaplin, 
2018).  
 
2.3 Function of Vitamin D  
The roles of vitamin D in human health can be divided into two categories, classic and non-classic. The 
former being the well-established, endocrine role in bone mineral homeostasis and the latter being a 
wider range of extra-skeletal functions. Non-classical roles include involvement in the immune system, 
the central nervous system, cell proliferation and in cardiovascular health (Gil et al., 2018; Humble, 
2010; Pike, Meyer, Lee, Onal, & Benkusky, 2017; Wang et al., 2017). At this point in time there is no 
general consensus around the mechanisms behind these non-classical roles thus are not included in 
public health initiatives.  
  
2.3.1 Bone 
Vitamin D’s endocrine function in bone mineral homeostasis ensures that the serum concentration of 
calcium and phosphate remains stable (Gil et al., 2018; Pike & Christakos, 2017). These two minerals 
give rise to hydroxyapatite; a mineral matrix that gives bone its rigidity and strength (Bonjour, 2011). 
In its active form of calcitriol, vitamin D upregulates intestinal absorption and renal reabsorption of 
these minerals thus preserving skeletal stores (Christakos, Dhawan, Porta, Mady, & Seth, 2011; Gil et 
al., 2018; Pike & Christakos, 2017). Calcitriol can also act to regulate bone mineralisation. Given that 
bone is a large reservoir of these minerals, bone mineral resorption will increase serum calcium levels 
when dietary intake of the mineral is lacking (Gil et al., 2018; Pike & Christakos, 2017). Osteoblastic 
expression of RANKL is stimulated by calcitriol which in turn activates osteoclasts and thus promotes 




To maintain normal function, calcitriol is regulated by the enzymes responsible for its activation and 
degradation; 1-hydroxylase and 24-hydroxylase respectively (Gil et al., 2018; Pike & Christakos, 
2017). Two hormones, fibroblast growth factor 23 (FGF23), secreted predominantly by osteoblasts, 
and parathyroid hormone (PTH), secreted from the parathyroid gland, regulate the expression of the 
two enzymes and are released in response to extracellular phosphate and calcium levels respectively 
(Gil et al., 2018; Pike & Christakos, 2017).  
 
2.3.2 Immune Function 
Studies in rachitic children began to note an association between this condition and respiratory tract 
infections. Originally this was thought to be a result of bone deformities impacting lung function. 
Advancements in this field of research however, have identified the cellular mechanisms by which 
vitamin D impacts the immune system functioning (Yakoob et al., 2016). A key advancement being 
identification of VDR and 1-hydroxylase expressed in tissues that do not have an association with 
bone mineral homeostasis (Prietl, Treiber, Pieber, & Amrein, 2013; Wei & Christakos, 2015). From 
here, many cells of the immune system were identified as having a relationship with vitamin D. Within 
the innate immune system, vitamin D appears to promote differentiation of monocytes into 
macrophages and enhance their antimicrobial functions, phagocytosis and chemotaxis (Baeke, 
Takiishi, Korf, Gysemans, & Mathieu, 2010; Prietl et al., 2013). Furthermore, the vitamin may promote 
transcription of cathelicidin and beta-defensin; antimicrobial peptides that functions by destroying 
the integrity of microbial membranes (Baeke et al., 2010; Prietl et al., 2013).   
 
Within the adaptive immune system, it has been proposed that vitamin D may downregulate B cell 
function. In doing so, vitamin D may have a protective role against autoimmune conditions given that 
B cells secrete antibodies. When autoreactive, these antibodies contribute to the aetiology of 
autoimmunity (Prietl et al., 2013; Walker & Modlin, 2009; Wu, Lewis, Pae, & Meydani, 2018). Secondly, 
vitamin D may influence T cell function in that it down regulates T cell secretion of pro-inflammatory 
cytokines. Vitamin D also promotes differentiation of T cells into Th2 cells and regulatory T cells which 
function to be anti-inflammatory and to prevent hyper- or misdirected immune responses (Prietl et 
al., 2013; Walker & Modlin, 2009; Wu et al., 2018).  
 
The 2012 New Zealand Consensus Statement on Vitamin D concluded that there was not enough 
evidence to develop public health messages that incorporate vitamin D for immune health. The 
consensus statement has not since been reviewed however much of the evidence around vitamin D 
for immune function evolved after this time.  
 
2.4 Outcomes of Vitamin D Deficiency  
 
2.4.1 Classic Outcomes  
Similar to the functions of vitamin D, outcomes of deficiency can be classified as classic and non-
classic. Classically, vitamin D deficiency has been associated with diseases of the skeletal system that 
effect the integrity and function of bone; this includes rickets in children and osteomalacia or 
osteoporosis in adults (Theodoratou, Tzoulaki, Zgaga, & Ioannidis, 2014). Outside of bone structure, 
calcium and phosphate have a variety of roles such as in cell signalling, neurotransmission and in 
muscle function (Shaker & Deftos, 2018). Serum levels of calcium, and to a slightly lesser extent 
phosphate, are tightly regulated within a very narrow range to preserve the variety of roles these 
minerals have (Shaker & Deftos, 2018).  When vitamin D is insufficient, serum calcium and phosphate 
concentrations cannot be maintained at an adequate level and will be resorbed from bone (Civitelli & 
Ziambaras, 2011; Silva & Bilezikian, 2015; van Driel & van Leeuwen, 2017). Receptors located in the 
membrane region of the cells of the parathyroid gland detect serum calcium levels and secrete PTH in 
response to hypocalcaemia (Civitelli & Ziambaras, 2011; Silva & Bilezikian, 2015).  
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PTH acts to increase serum calcium via upregulation of renal calcium resorption and calcium 
liberation from bone via stimulation of osteoclastic bone remodelling (Civitelli & Ziambaras, 2011; 
Silva & Bilezikian, 2015). Chronic vitamin D deficiency therefore results in weakened bone structure 
secondary to bone lacking sufficient mineral density (Anderson et al., 2008).   
 
2.4.2 Non-Classic Outcomes 
In more recent years, research has turned towards non-classical outcomes outside of the skeletal 
system. The potential implications of vitamin D deficiency include increased risk of certain cancers 
such as colon, breast and prostate (Baggerly et al., 2015; Holick, 2008a); autoimmune conditions such 
as rheumatoid arthritis, multiple sclerosis, inflammatory bowel disease and type 1 diabetes (Feng et 
al., 2015; Harrison, Li, Jeffery, Raza, & Hewison, 2019; Kabbani et al., 2016; Pierrot-Deseilligny & 
Souberbielle, 2017); infectious diseases, mental health disorders and cardiovascular disease (Gil et al., 
2018; Humble, 2010; Pike & Christakos, 2017; Theodoratou et al., 2014). At present, the evidence for 
prophylactic or interventional use of vitamin D is largely inconclusive and screening for vitamin D 
deficiency is not a front-line strategy for prevention of the aforementioned conditions (Holick, 2011; 
Theodoratou et al., 2014).  
 
2.5 Prevalence of Vitamin D Deficiency  
 
2.5.1 Defining Deficiency  
To explore the prevalence of vitamin D deficiency, sufficiency and deficiency must first be defined. 
The gold standard for measurement of vitamin D status is high performance liquid chromatography 
tandem mass spectrometry (Holick, 2009). This method is used to measure serum 25(OH)D, the 
preferred metabolite used to define vitamin D status. Although no globally accepted guideline exists, 
most organisations, including the New Zealand Ministry of Health, agree that serum 25(OH)D is 
adequate when at a level of 50 nmol/L or above; a level of 24 nmol/L or below signals deficiency 
(Ministry of Health and Cancer Society of New Zealand, 2012). Other organisations such as the 
Endocrine Society believe that vitamin D deficiency should be defined as a serum 25(OH)D level below 
50nmol/L and insufficiency as a serum 25(OH)D level below 75nmol/L (Holick et al., 2011). For the 
purpose of this study, vitamin D levels defined by the New Zealand Ministry of Health have been used 
for reference when discussing vitamin D status. Clinical manifestations include bone pain, delayed 
growth, delayed standing and walking and frequent falling in children. In adults, it may present as 
bone pain, fractures and muscle weakness (Bordelon et al., 2009; Thacher & Clarke, 2011; van Schoor 
& Lips, 2018).  
 
2.5.2 Prevalence of Vitamin D Deficiency in New Zealand 
Given the array of method of determining vitamin D status, nor is there a universally accepted range 
by which vitamin D status is defined, comparing trends in deficiency between populations can be 
problematic. Despite these challenges, there is evidence to suggest that vitamin D deficiency is making 
a resurgence on a global level (Hilger et al., 2014; Mithal et al., 2009). In New Zealand, sub-optimal 
vitamin D concentrations have been observed in several age brackets. In a study of 925 healthy new-
borns, one in five were found to have cord blood concentrations of 25(OH)D below 25nmol/L 
(Camargo et al., 2010). A further two studies that included children between the ages of six and twenty 
three months of age identified prevalent vitamin D insufficiency in early childhood dependent on 
ethnicity and the season in which the status was measured (Grant et al., 2009; Houghton et al., 2010). 
The chemiluminescence immunoassay and radioimmunoassay methods used for determining 
25(OH)D levels in these studies however, have been shown to produce results of poorer accuracy 
compared to the preferred method, high performance liquid chromatography (Snellman et al., 2010). 
Delshad et al. reported that 25.6% of the 507 participants between the ages of eight and 11 years had 
25(OH)D concentrations below 50nmol/L (Delshad et al., 2019).  
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Using lower cut off values, in a study of 1585 children aged five to fourteen 31% were identified as 
being vitamin D insufficient (<37.5nmol/L) and a further 4% as deficient (<17.5nmol/L) (Rockell et al., 
2005). The generalisability of this study is strengthened by the relatively even representation of New 
Zealand European, Māori and Pacific ethnicities within the sample population.  
Using the same cut off of 17.5nmol/L, a study of 2946 men and women aged 15 years and over found 
that 4% of the participants were deficient; 48% were found to be insufficient when using the common 
cut off of 50nmol/L (Rockell et al., 2006). The latter value is much higher than findings from the 
2008/09 Adult Nutrition Survey where 27.1% of participants within this age group were identified as 
being deficient (Ministry of Health, 2012). Suboptimal vitamin D levels have been identified in post-
menopausal women but were less common in men of similar age (Bolland et al., 2006; Lucas et al., 
2005).      
 
2.6 Risk Factors for Deficiency in the General Population 
 
2.6.1 Sun Exposure  
Australasian adults acquire 90-95% of their daily vitamin D dose via endogenous synthesis following 
exposure to UV (Nowson et al., 2012). Therefore, the greatest risk factor for vitamin D deficiency is 
inadequate exposure to sunlight (Nowson et al., 2012). Groups at risk of inadequate sunlight exposure 
include those who are housebound, institutionalised or regularly spend large amounts of daylight 
hours inside (Nowson et al., 2012).  
 
Inhabitants of New Zealand are exposed to greater amounts of UVR due to a comparative lack of air 
pollution and depletion of ozone (McKenzie, 2017; Pondicherry et al., 2018). Despite the higher levels 
of UVR, vitamin D deficiency is possible and increasingly prevalent within this country (Nowson et al., 
2012).  
 
2.6.2 Sun Protection Behaviours 
Rates of skin cancer in New Zealand are some of the highest in the world (Apalla, Lallas, Sotiriou, 
Lazaridou, & Ioannides, 2017; McKenzie, 2017; Pondicherry et al., 2018). This is secondary to the 
aforementioned depletion of ozone, the atmospheric gas which absorbs UVR thus reducing its 
mutagenic effects (Abbasi & Abbasi, 2017). Beliefs about skin cancer risk may therefore influence 
sunlight exposure behaviours and subsequently, the vitamin D status of New Zealand populants.  
 
A study of 110 New Zealand-based outdoor athletes found that participants expressed greater 
concern about skin cancer risk than their vitamin D status. Only 10% of participants however reported 
always applying sunscreen before spending time in the sun suggesting that awareness of skin cancer 
risk may not be correlated to changing sun exposure behaviours (Walker et al., 2014). A study of 140 
South Asian women living in New Zealand reported similar results with 20% of participants 
commenting on the strength of New Zealand’s sunshine, ozone depletion and skin cancer risk. 
Furthermore, 49% of participants indicated they would spend more time in the sun if they were not 
concerned about skin cancer. Only 17% of participants however reported always using sunscreen 
when going outside (von Hurst et al., 2010). Despite growing concern that skin cancer and sun 
avoidance messages are contributing to an increase in vitamin D deficiency, the evidence linking 
beliefs about skin cancer and sun exposure practices doesn’t appear to support this hypothesis in the 




In Australian-based studies however, where the UVR environment is similar, beliefs and subsequent 
behaviours appear to share a stronger correlation. A study of 2001 residents from Queensland, 
Australia found that participants who agreed that regular protection of their skin from the sun 
increased the risk of an inadequate vitamin D status, were more likely to never use sunscreen. 
Similarly, participants who did not agree were more likely to use sunscreen always or most of the time 
(Youl et al., 2009). Again, a study of 1971 office workers residing in Brisbane, Australia reported that 
participants who believed sun protective behaviours may cause vitamin D deficiency, indicated less 
frequent use of sunscreen (Vu, van der Pols, Whiteman, Kimlin, & Neale, 2010).  
 
Whilst in a laboratory setting sunscreen greatly reduces the cutaneous production of vitamin D 
(Matsuoka, Ide, Wortsman, Maclaughlin, & Holick, 1987), several non-experimental studies have 
yielded conflicting results. In a 2019 review of 75 international studies, four experimental studies were 
able to associate sunscreen use with decreased vitamin D production. The remaining observational 
and field studies found no effect on or higher vitamin D levels associated with sunscreen use (Neale 
et al., 2019). A further study of 103 Sydney-based adults found a statistically significant association 
between sunscreen use and higher vitamin D levels (Fayet-Moore et al., 2019). It was concluded that 
sunscreen application outside of an experimental setting does not typically adhere to recommended 
application frequency and concentration, thus a reduction in cutaneous vitamin D production is not 
observed (Fayet-Moore et al., 2019). Use of long clothing for protection against the sun however has 
been associated with reduced cutaneous vitamin D production (Springbett et al., 2010).  
 
The evidence surrounding sun protection behaviours and their impact on vitamin D status is 
conflicting. Individuals should continue to use protective clothing and apply sunscreen when outdoors 
as per the Cancer Society guidelines to reduce the risk of developing skin cancer (Cancer Society of 
New Zealand, 2017). This is particularly important within the hours of 10am to 4pm during the warmer 
months of September through to April where UVR is at its strongest in New Zealand. During these 
warmer months, the 2012 New Zealand Consensus Statement recommends partaking in some form 
of outdoor physical activity outside of these hours to allow for cutaneous vitamin D synthesis with less 
risk of sun damage. Sun exposure outside of the peak sunlight hours is necessary as UV must come 
into contact with the skin directly to stimulate cutaneous vitamin D synthesis; UV cannot penetrate 
through glass windows. Exposure to sunlight is not safer behind glass however, as the more 
carcinogenic UV is able to penetrate glass (Khan, Travers, & Kemp, 2018).  
 
2.6.3 Ethnicity  
Aside from sun protection, long clothing may be worn for cultural or religious regions. A 2019 study 
of 90 Kuwait females found that participants wearing a hijab or veil were more likely to be deficient 
in vitamin D (Al-Yatama, AlOtaibi, Al-Bader, & Al-Shoumer, 2019). These findings are very applicable 
given the continuing growth of the Middle Eastern population in New Zealand (Statistics NZ, 2019). In 
a New Zealand based study, vitamin D levels below 50nmol/L were identified in Middle Eastern 
women. Mazahery et al. reported that the mean serum 25(OH)D concentrations amongst 61 Middle 
Eastern female participants in two experimental groups was 44±16nmol/L and 48±11nmol/L 
(Mazahery, Stonehouse, & Von Hurst, 2015). 
 
It is important to note the skin tone of the participants in the 2019 study as all were olive skinned (skin 
type IV). The concentration of an individual’s melanin pigmentation influences their capability to 
cutaneously synthesise vitamin D. This is because melanin acts as a natural sunscreen by absorbing 
UV thus preventing damage to the underlying layers of the skin. As a result, UV photons are less 
available for absorption by 7-DHC. Individual’s with darker skin tones and thus more melanin are 
therefore at greater risk of vitamin D deficiency despite achieving regular sunlight exposure (Webb et 
al., 2018).  
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Delshad et al. reported that children in their study with dark or brown skin colour had lower mean 
25(OH)D levels (51±18nmol/L) than the New Zealand European participants (75±20nmol/L) (Delshad 
et al., 2019).  
 
In New Zealand’s UVR conditions, it has been proposed that individuals with darker skin tones require 
sun exposure that is three to six times longer in duration than their fairer skinned counterparts 
(Nowson et al., 2012). Ethnicity is often used to categorise skin tone in New Zealand guidelines 
(Nowson et al., 2012). Migration and inter-ethnic marriages however, have led to a disassociation 
between ethnicity and skin colour (Callister, Galtry, & Didham, 2011). This highlights need for caution 
and specificity when promoting safe sun exposure guidelines for vitamin D synthesis and skin cancer 
prevention (Callister et al., 2011). 
 
2.6.4 Season and Latitude  
Winter months and higher latitudes reduce the intensity of UV as a result of the earth being at a 
greater distance from the sun, therefore impacting cutaneous vitamin D synthesis (Godar, 2005). It 
has been documented that cutaneous vitamin D synthesis may not occur for some months out of the 
year at latitudes of 50 and above as UVR is inadequate to stimulate production (Engelsen, Brustad, 
Aksnes, & Lund, 2005).  
 
During New Zealand’s winter, the southern region which sits at 40-47 receives half the amount of 
UVR than the northern region which sits at 35-40 (McKenzie, Bodeker, Keep, Kotkamp, & Evans, 1996; 
Rockell et al., 2005). In 2015, a New Zealand prospective surveillance study identified greater 
incidence of rickets in children living in southern regions of the country (Wheeler et al., 2015). A more 
recent 2017 New Zealand study however found no geographical differences in vitamin D levels 
between the 1329 children under five years old that were recruited (Cairncross et al., 2017). The 
former study found the greatest number of cases following winter highlighting the impact of 
seasonality, whereas the latter study was itself conducted during late winter, so the seasonal patterns 
were not able to be analysed. In a New Zealand study of 1606 healthy women who were post-
menopausal and over the age of 54, seasonal differences in vitamin D levels were statistically 
significant with 0-3% of the participants deficient in summer versus 6-15% in winter (Lucas et al., 
2005).  
 
The evidence for latitude alone appears conflicting however in conjunction with seasonality, the 
impact is more defined. Findings from the 2008/09 New Zealand Adult Nutrition Survey highlighted 
that latitude and season had a combined effect as inhabitants of South New Zealand were 3.1 times 
more likely to be deficient in vitamin D from August through to October (Ministry of Health, 2012). 
Latitude alone did not yield statistically significant differences in vitamin D status (Ministry of Health, 
2012).  
 
The 2012 New Zealand Consensus Statement on Vitamin D recommends participating in outdoor 
physical activity around midday with face, arms and hands exposed to optimise cutaneous vitamin D 
synthesis during the colder months of May through to August. Furthermore, inhabitants of the 
Southern region of New Zealand who spend minimal time outdoors from May to August are 
recognised as an at-risk population (Ministry of Health and Cancer Society of New Zealand, 2012).  
 
2.7 Vitamin D in Pregnancy  
Maternal vitamin D stores provide the sole source of vitamin D for the developing fetus. During 
pregnancy, maternal vitamin D metabolism is upregulated and is characterised by increased serum 
calcitriol, DPB and renal 1-hydroxylase. Furthermore, there is expression of placental VDR and 1-
hydroxylase (Agarwal, Kovilam, & Agrawal, 2018; Pludowski et al., 2013).  
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2.7.1 Supplementation with Vitamin D During Pregnancy  
Primarily, upregulation of maternal vitamin D metabolism occurs to ensure adequate calcium 
provision for fetal bone mineralisation (Agarwal et al., 2018; Pludowski et al., 2013). As research has 
developed beyond the skeletal function however, maternal vitamin D deficiency has been associated 
with several adverse health outcomes in both the mother and neonate (Agarwal et al., 2018; 
Pludowski et al., 2013). The Companion Statement to the 2012 New Zealand Consensus Statement on 
Vitamin D concluded there was not enough evidence in support of vitamin D supplementation during 
pregnancy for the prevention of these outcomes.  
 
The Cochrane Review however, which this conclusion was based on, has since been updated (Palacios 
et al., 2019). Vitamin D supplementation during pregnancy may reduce the risk of pre-eclampsia, 
gestational diabetes meletus (GDM) and severe post-partum haemorrhage. Risk of pre-term birth is 
unlikely to be reduced with vitamin D supplementation. The Cochrane review reported however, that 
when vitamin D and calcium were supplemented together, the risk of pre-term birth was increased 
(Palacios et al., 2019). This highlights the need for both further research and clear supplementation 
guidelines.  For the neonate, maternal vitamin D supplementation may reduce the risk of low 
birthweight (Palacios et al., 2019). 
 
The 2012 New Zealand Consensus Statement on Vitamin D reported that prophylactic 
supplementation may be beneficial however, if a pregnant woman meets one or more of the at-risk 
criteria for deficiency. Pregnant women share the same risk factors for deficiency as the general 
population (Ministry of Health and Cancer Society of New Zealand, 2012).   
 
A PHARMAC-funded vitamin D supplement designed specifically for at-risk pregnant women does not 
exist, however these women may be prescribed vitamin D as per preparations available for the general 
population (Best Practice Advocacy Centre New Zealand, 2011; Ministry of Health, 2013a). The 
standard supplement being a once monthly 1.25mg cholecalciferol tablet (Ministry of Health, 2013a; 
Ministry of Health and Cancer Society of New Zealand, 2012). Over-the-counter multi-vitamin 
preparations designed for pregnant women contain vitamin D; these are available without 
prescription however tend to carry a greater cost and additional risks as outlined in previously.   
 
2.7.2 Prevalence of Deficiency in Pregnant Women   
Pregnant women are more susceptible to deficiency secondary to the fetus requiring vitamin D for 
growth and development; accrual of fetal bone mass occurs primarily in the third trimester therefore 
risk of maternal deficiency is greater during this time (Wheeler et al., 2018). Furthermore, infant 
vitamin D status has been found to correlate with maternal vitamin D status, particularly during the 
third trimester (Wheeler et al., 2018). It is recommended however, that at-risk pregnant women in 
Australia and New Zealand undergo measurement of serum vitamin D levels early in their first 
trimester (Paxton et al., 2013); deficiency that develops later in pregnancy or in women that are not 
classified as at risk, may therefore go undetected (Wheeler et al., 2018), suggesting that more 
widespread and increased frequency of testing may be beneficial. Additionally, the NRVANZ for 
vitamin D throughout pregnancy is 5g as per the general population. This value is based on research 
articles from 1978 and 2004 therefore does not account for recent advancements in understanding 
the role of vitamin D during pregnancy (Ministry of Health, 2006b).   
 
A longitudinal study of 80 pregnant, New Zealand-based women living at a latitude of 45 identified 
vitamin D levels below 50nmol/L in 65% of the participants (Wheeler et al., 2018).  This study also 
noted that deficiency was frequent in women categorised as low-risk, suggesting current guidelines 
to screen only at-risk pregnant women may not be a sufficient (Wheeler et al., 2018). In a study of 259 
pregnant women living at a latitude of 36 in New Zealand, 109 women had vitamin D levels below 
50nmol/L whilst 11 had levels below 25nmol/L (Ekeroma et al., 2015).  
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Vitamin D levels below 50nmol/L were identified in 772 pregnant women from a study population of 
2800 recruited in both Auckland, New Zealand and Adelaide, Australia (Wilson et al., 2018). Finally, 
findings from the 2008/09 New Zealand Adult Nutrition Survey identified one third of the 2204 women 
of childbearing age involved in the study as having vitamin D levels below 50nmol/L (Ministry of 
Health, 2012). Evidence of vitamin D deficiency amongst pregnant women has been observed in the 
New Zealand population, despite the availability of prevention guidelines (Ministry of Health, 2013a; 
Ministry of Health and Cancer Society of New Zealand, 2012).   
 
2.7.3 Extra-Skeletal Adverse Maternal Health Outcomes of Vitamin D Deficiency 
 
2.7.3.1 Pre-Eclampsia  
Characterised by hypertension and proteinuria, pre-eclampsia is a life-threatening condition for both 
mother and fetus. As well as mortality, the developing fetus is at risk of intrauterine growth restriction 
secondary to restricted blood supply; the mother is at risk of pulmonary oedema, organ damage and 
defective blood coagulation (Yuan et al., 2019).  The mechanisms by which vitamin D is involved in 
prevention of pre-eclampsia are not clear however may relate to vitamin D’s proposed 
immunomodulatory function (Agarwal et al., 2018). Furthermore, it has been suggested that vitamin 
D influences the Renin Angiotensin System and angiogenesis thus aiding in blood pressure regulation 
(Agarwal et al., 2018; Ullah, Uwaifo, Nicholas, & Koch, 2010).  
 
Much of the evidence linking vitamin D with pre-eclampsia has highlighted association opposed to 
causation. A French case-control study of 402 pregnant women found no statistically significant 
association between low levels of vitamin D and pre-eclampsia risk in the first trimester. During the 
third trimester however, vitamin D levels exceeding 75nmol/L were associated with a significantly 
lower risk of pre-eclampsia (Benachi et al., 2019). A Canadian prospective cohort study of 221 women 
who were deemed high risk for pre-eclampsia found a high prevalence of vitamin D insufficiency and 
deficiency. The study was unable to associate the lower levels of vitamin D to their pre-eclampsia risk, 
however (Shand, Nassar, Von Dadelszen, Innis, & Green, 2010).  In more recent years, several meta-
analyses have been published that report a significant association between vitamin D levels below 
50nmol/L and increased pre-eclampsia risk (Akbari, Khodadadi, Ahmadi, Abbaszadeh, & Shahsavar, 
2018; Palacios et al., 2019; Yuan et al., 2019).   
 
2.7.3.2 Gestational Diabetes Meletus  
Glucose intolerance and subsequent hyperglycaemia during pregnancy is a risk factor for developing 
type two diabetes later in life for both the mother and infant; furthermore, the infant is at greater risk 
of childhood obesity (Ojo, Weldon, Thompson, & Vargo, 2019). VDR is expressed in pancreatic  cells; 
it has been suggested that vitamin D has a role in regulation of insulin secretion (Amraei et al., 2018). 
Furthermore it has been suggested that replenishing Vitamin D in deplete pregnant women improves 
tissue sensitivity to insulin (Amraei et al., 2018). Several recent meta-analyses that included 75 
observational studies and over forty-five thousand participants between them, found significant 
associations between low levels of vitamin D and increased risk of GDM (Amraei et al., 2018; Hu et al., 
2018; Lu, Xu, Lv, & Zhang, 2016). Furthermore, vitamin D levels were significantly lower in women 
with GDM (Amraei et al., 2018). In a 2019 meta-analysis of five, randomized controlled trials, there 
was a significant association between vitamin D supplementation and improved glycaemic control in 




2.7.3.3 Pre-Term Birth  
Babies born before 37 weeks’ gestation are at risk of severe developmental disabilities and mortality 
(Qin, Lu, Yang, Xu, & Luo, 2016). In the year 2017, 7.5% of live births in New Zealand were pre-term 
(Ministry of Health, 2019). There is emerging evidence that vitamin D has a role in reducing the risk of 
pre-term birth (PTB) however the results have been conflicting and the mechanisms behind this 
association remain unclear (Qin et al., 2016). A case-cohort study of 3453 pregnant women found risk 
of PTB was higher in those with vitamin D levels below 50nmol/L (Bodnar, Platt, & Simhan, 2015). 
These findings were similar to a study of 192 pregnant women where mothers who delivered pre-
term were found to have lower levels of vitamin D than those delivering at term (Thota et al., 2014). 
In a meta-analysis of 11 observational studies, pregnant women with vitamin D levels below 50nmol/L 
had a significantly increased risk of PTB (Qin et al., 2016). Furthermore, a meta-analysis of 26 
randomized controlled trials and observational studies identified a significant association between 
PTB risk and vitamin D deficiency (Zhou, Tao, Huang, Zhu, & Tao, 2017).  
 
Interventional studies that have trialled supplementation with vitamin D to reduce the risk or 
incidence of PTB however, have found less significant results (Agarwal et al., 2018; Palacios et al., 
2019). Despite the inconclusiveness, PTB is a significant public health concern and further research is 
required to understand the association between vitamin D and PTB.   
 
2.7.3.4 Small for Gestational Age 
Neonates born SGA have higher rates of morbidity and mortality. In the year 2017, 2.9% of all live-
births in New Zealand were SGA (Ministry of Health, 2019). Vitamin D deficiency is thought to be 
associated with risk of SGA secondary to predisposing poor bone mineralisation (Khalessi, Kalani, 
Araghi, & Farahani, 2015). A 2017 meta-analysis of 13 prospective cohort studies found a significant 
association between maternal vitamin D levels below 50nmol/L and increased risk of SGA infants 
(Chen, Zhu, Wu, Li, & Tao, 2017). Similarly, a 2018 meta-analysis of 12 observational studies found 
that pregnant women with vitamin D levels below 50nmol/L exhibited greater risk of birthing an infant 
who is SGA. Evidence from interventional trials further support this association; a 2018 meta-analysis 
of 24 randomized, controlled trials found a significantly lower risk of birthing an SGA infant in the 
mothers prescribed a vitamin D supplement (Bi et al., 2018). Although limited, evidence from the New 
Zealand population does not support this association. In a 2016 prospective cohort study, 9.9% of the 
1710 pregnant women gave birth to an SGA infant. This study found no significant association between 
lower maternal levels of vitamin D and this pregnancy outcome.  
 
2.8 Vitamin D in Infancy  
The prevalence of vitamin D deficiency amongst New Zealand infants has previously been discussed 
in this literature review (Camargo et al., 2010; Grant et al., 2009; Houghton et al., 2010). Additional 
risk factors for deficiency in this population group are maternal deficiency and preterm birth given the 
infant’s dependence on maternal stores during pregnancy as previously discussed; preterm birth is 
therefore a risk factor as a shorter length of gestation interrupts fetal accretion of vitamin D (Rigo & 
Senterre, 2006; Wheeler et al., 2018). Furthermore, exclusive breastfeeding and inadequate sun 
exposure may contribute to suboptimal vitamin D status (Ministry of Health, 2013a).  
 
Research suggests that the barrier function of infant skin is immature for up to the first two years of 
life and that sunburn during infancy carries greater risk of developing skin cancer (Shafie Pour et al., 
2015). For this reason, the Companion Statement to the New Zealand Consensus Statement on 
Vitamin D recommends that until independently mobile, infants should not be deliberately exposed 
direct sunlight. During this period, infants who receive minimal sun exposure as per these guidelines 
are largely dependent on dietary vitamin D; dependency increasing when the infant is dark-skinned, 
lives at high latitude, or during the winter months as these factors further contribute to reduced 
cutaneous vitamin D production (Ministry of Health, 2013a).  
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Breast milk, potentially a sole food source for up to the first six months of life, contains very little 
vitamin D (Wheeler et al., 2015). In 2018, Plunket reported that 22% of New Zealand infants in their 
database were exclusively breastfed for the first six months of life, 47% for three months and 53% for 
six weeks (Plunket, 2020).   
 
The Ministry of Health recommends exclusive breastfeeding until around the age of six months 
(Ministry of Health, 2008a); this guideline should continue to be emphasized and strategies to manage 
the vitamin D status of an infant must complement this without contradicting sun exposure guidelines 
for the infant population. Maternal supplementation with vitamin D has been associated with 
improving the vitamin D concentration in breastmilk to the point of superseding requirements for sun 
exposure (Dawodu & Tsang, 2012). A RCT by Hollis et al. reported that a daily vitamin D supplement 
of 6400 international units (IU) per day safely increased the vitamin D content of breastmilk to a level 
that was sufficient for meeting the infant’s vitamin D requirements (Hollis et al., 2015). This regime is 
much higher than the monthly 50,000IU dose currently subsidised by PHARMAC (Ministry of Health, 
2013a).  
 
A New Zealand based study however, reported that maternal dietary vitamin D intake, maternal 
supplement use and maternal sun exposure were not independently associated with exclusively 
breastfed infants’ serum vitamin D concentration, thus supporting that exclusive breastfeeding is a 
risk factor for deficiency (Lovell et al., 2016). Median daily dietary intake was estimated as 158IU; the 
vitamin D content of supplements ranged between 100IU and 800IU (Lovell et al., 2016). Given that 
maternal supplementation for this purpose is not currently included in New Zealand guidelines, 
exclusive breastfeeding remains as a recognised risk factor for deficiency (Ministry of Health, 2013a).  
 
2.8.1 Supplementation with Vitamin D During Infancy 
The Companion Statement to the 2012 New Zealand Consensus Statement on Vitamin D recommends 
that full-term, exclusively or partially breastfed infants who have one or more risk factors for 
deficiency receive a vitamin D supplement. At the time of publication, Vitadol-C, a vitamin A-, C- and 
D-containing supplement, was the only infant-specific preparation available under the PHARMAC 
schedule. Since this time, PHARMAC has opted to fund a liquid-form cholecalciferol supplement 
beginning in 2019 (PHARMAC, 2018). A 2015 prospective surveillance study conducted in New Zealand 
found that four of the 58 children diagnosed with nutritional rickets had received a vitamin D 
supplement during infancy. Of these children, 93% were exclusively breastfed as an infant and 81% 
had intermediate to dark skin tones (Wheeler et al., 2015). This study identified that despite these 
children presenting with risk factors for deficiency prior to diagnosis of rickets, only a small number 
received supplementation from their health care practitioner as per the guidelines.  
 
At present, the Companion Statement to the 2012 New Zealand Consensus Statement on Vitamin D 
discusses vitamin D supplementation with regards to bone health. Outside of the skeletal system 
however, vitamin D deficiency has more recently been associated with several conditions that are 
common in childhood including asthma, respiratory infections, eczema and food allergies (Saggese et 
al., 2015). The mechanism by which vitamin D is thought to influence the aetiology these conditions 
is immunomodulation (Saggese et al., 2015). In context of the New Zealand population, no large-scale 
interventional trials have been conducted however a study of 1329 children between the ages of two 
and five found no association between vitamin D levels and eczema, asthma or allergic 




2.8.2 Extra-Skeletal Adverse Infant Health Outcomes of Vitamin D Deficiency   
 
2.8.2.1 Respiratory Tract Infections and Asthma 
The immunomodulatory role of vitamin D was alluded to when researchers found a high prevalence 
of respiratory tract infections amongst rachitic children (Yakoob et al., 2016). Following this, a large 
number of studies have looked into this association however the results have been conflicting; the 
evidence appears much stronger in developing countries. Despite the conflict, this is a relevant 
outcome in context of the New Zealand population given the country has a higher rate of 
hospitalisation for acute respiratory tract infections (ARTI) in children compared to other developed 
countries (Simpson et al., 2013). In a RCT involving 173 New Zealand-based pregnant women and their 
infants receiving a high or low dose vitamin D supplement, a smaller number of infants from the high 
dose group made health care visits for an ARTI compared to the placebo group. This suggests vitamin 
D may have had a protective role against contracting an ARTI. This finding was not statistically 
significant, however (Grant et al., 2015).  A secondary analysis of a RCT was conducted with 960 
children under the age of 30 months from Delhi, India. The risk of ARTI was found to be significantly 
higher in participants with vitamin D levels below 25nmol/L (Chowdhury et al., 2017).  Similarly, in a 
study of 922 new-borns, cord-blood vitamin D level had a significant, inverse association with ARTI 
risk.  A  2015 systematic review of seven RCTs however found no significant association between 
vitamin D supplementation and prevention of childhood ARTI (Xiao et al., 2015). Additionally, a 2016 
Cochrane Review found no significant impact of vitamin D supplementation in children with 
respiratory tract infections (Yakoob et al., 2016).   
 
Evidence is also growing in support of vitamin D functioning to reduce incidence of asthma 
exacerbation. This finding has been supported by a meta-analysis of 8 RCTs, one of which reported 
significantly lower rates of emergency department visitation in children receiving a vitamin D 
supplement (Cassim et al., 2015). Similarly, a systematic review of 23 studies found risk of asthma 
exacerbation was lower in children with higher vitamin D levels (Riverin, Maguire, & Li, 2015). Without 
reaching statistical significance, a RCT involving 581 pregnant women found a 25% reduction in risk of 
developing asthma between the ages of zero to three years in infants birthed by mothers who received 
a vitamin D supplement during pregnancy (Wolsk et al., 2017).  This finding, although not currently 
supported in the New Zealand population (Cairncross et al., 2016), is of importance given the rate of 
childhood asthma within this population is amongst the highest internationally (Cairncross et al., 
2016). A 2016 Cochrane Review of vitamin D supplementation for asthma management found a 
statistically significant reduction in risk of asthma exacerbations that require emergency room 
attendance or hospitalisation (Martineau et al., 2016). This review included a larger proportion of 
adult opposed to paediatric cases therefore results must be interpreted with caution when 
generalising to the paediatric population alone.  
 
2.8.2.2 Eczema      
An international meta-analysis of 34 observational studies identified the association between vitamin 
D deficiency and risk of childhood eczema as being stronger in higher latitudes (Pacheco‐González, 
García‐Marcos, & Morales, 2018).  This finding may be of interest to the New Zealand population given 
that the international Study of Asthma and Allergies in Childhood found a high prevalence of eczema 
amongst New Zealand children (Clayton et al., 2013).  The most current New Zealand-based 
observational research however, did not identify a significant association between vitamin D status 
and childhood eczema (Cairncross et al., 2016).  
 
Internationally, both maternal and neonatal vitamin D status has been associated with statistically 
significant risk of childhood eczema. A meta-analysis of six prospective cohort studies found a 
significant association between poor maternal vitamin D status and risk of childhood eczema (Wei, 
Zhang, & Yu, 2016).  
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Furthermore, a meta-analysis of 11 studies including seven observational and four clinical trials, 
identified significantly lower vitamin D levels in children with eczema compared to those without (Kim, 
Kim, Lee, Choe, & Ahn, 2016). 
 
2.8.2.3 Food Allergies 
Meta-analysis and systematic reviews specifically looking at the relationship between vitamin D status 
and food allergies are yet to be conducted. Results from cohort studies, however, suggest an 
association exists; the direction of which is conflicting. In a large, Australian cohort study, infants born 
to parents of Australian origin with vitamin D levels below 50nmol/L were more likely to have allergies 
to egg and peanuts. Furthermore, these infants were more likely to have multiple food allergies (Allen 
et al., 2013). Similarly, a report based on data from the Longitudinal Study in Australian Children has 
identified a latitudinal gradient in food allergy and eczema rates with populations at higher latitudes 
exhibiting greater incidence. The report suggested that this pattern highlights an association between 
vitamin D status and the disease states (Osborne, Ukoumunne, Wake, & Allen, 2012). A key finding 
from a German cohort study of 378 mothers and their infants, however, was that higher levels of 
vitamin D in mothers during pregnancy increased the risk of food allergy in their infants. Further RCTs 
and subsequent meta-analyses may be useful in developing a better understanding of this potential 
deficiency outcome. 
 
2.9 Vitamin D and the Health Practitioner   
Health professionals help to educate the population about vitamin D and its associated health 
benefits. Furthermore, health professionals can identify those who are at risk of deficiency and 
provide strategies to manage vitamin D status. In order to do so effectively, health professionals must 
have both sufficient and evidence-based knowledge about the topic (Dix et al., 2017).  
 
The 2012 New Zealand Consensus Statement on Vitamin D is a key piece of literature available to 
health professionals in New Zealand (Ministry of Health and Cancer Society of New Zealand, 2012). 
This document states the guidelines for management of vitamin D status in the general population. 
For pregnant women and infants, evidence-based guidelines are documented in the Companion 
Statement to the 2012 New Zealand Consensus Statement on Vitamin D (Ministry of Health, 2013a). 
Released in 2012 and 2013 respectively, no further documents have since been published. Given the 
change in research availability since this time, health professionals’ knowledge of vitamin D may be 
varied. Exploring this knowledge may provide some direction in bettering the guidelines available to 
health professionals and thus in providing better health outcomes for populations. Both national and 
international research is available that focuses on health professionals’ knowledge and current 
practices regarding certain aspects of vitamin D management (Bonevski et al., 2012; Dix et al., 2017; 
Oberhelman et al., 2018; Reeder et al., 2012; Reeder et al., 2013). These are reviewed in the following 
section.  
 
2.9.1 Knowledge of Deficiency Risk Factors  
Knowledge of certain deficiency risk factors appears varied by profession. An Australian cross-
sectional study used a survey to assess the knowledge of 500 general medical practitioners (GP). Poor 
recognition of dark skin as a deficiency risk factor was identified (Bonevski et al., 2012). Similarly, 
awareness of dark skin as a risk factor was moderate in a study of 1089 New Zealand-based GPs where 
55% of the study population correctly selected this answer (Reeder et al., 2013). An updated version 
of the survey developed by Bonevski et al. was completed by 134 Australian Dietitians. Greater 
recognition of dark skin as a deficiency risk factor was seen in this population (Dix et al., 2017). The 
small population size and low response rate of 3% however, means the results are unlikely to be an 
accurate representation of differences in knowledge between professions (Dix et al., 2017).  
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Furthermore, both studies involving GPs were conducted prior to release of their respective national 
guidelines, thus potentially giving the dietetic sample population, who were investigated following the 
release of an Australian and New Zealand Bone Mineral Society position statement on vitamin D and 
sun exposure, an advantage. Across all three studies, nearly all participants identified inadequate sun 
exposure and concealing clothing as risk factors for deficiency (Bonevski et al., 2012; Dix et al., 2017; 
Reeder et al., 2013). In a 2015 study of 158 health care physicians working in Saudi Arabia, awareness 
of dark skin and concealing clothing as factors that impact vitamin D status was reported as poor (Al-
Amri, Gad, Al-Habib, & Ibrahim, 2017).  
 
The three studies by Bonevski et al., Reeder et al., and Dix et al. shared similar limitations as all had 
low response rates, 32% being the highest which was achieved by the New Zealand study (Reeder et 
al., 2013), suggesting the population samples were unrepresentative. Furthermore, in both studies 
evaluating knowledge of GPs, comparisons between the sample populations and source populations 
identified overrepresentation of females and part-time employment (Bonevski et al., 2012; Reeder et 
al., 2012). With regards to survey design, each of the three studies have used several different risk 
factor response options. Response options may have influenced response patterns and thus 
inaccurately represented knowledge between the professions (Reeder et al., 2013). A limitation of the 
work by Dix et al., and Al-Amri et al. is the small sample population of 134 and 158 respectively.   
 
2.9.2 Knowledge and Attitudes Toward Sun Exposure Guidelines  
Using surveys, Bonevski et al., Reeder et al. and Dix et al. explored health professionals’ knowledge of 
sun exposure guidelines for vitamin D synthesis. Across all three studies, there was confusion 
surrounding the amount of UVR exposure that is required for cutaneous vitamin D synthesis during 
winter (Bonevski et al., 2012; Dix et al., 2017; Reeder et al., 2012).  
 
In the New Zealand study, majority of GPs correctly recommended use of sun protection methods 
during peak UVR times in summer months (Reeder et al., 2012). The study identified however, that 
many GPs continue to recommend sun avoidance during peak UVR hours into the winter months 
which may contribute to insufficient cutaneous vitamin D synthesis (Reeder et al., 2012). These 
findings were similar in the Australian study of GPs were under 20% of participants reported advising 
use of less sun protection in winter (Bonevski et al., 2012). Within the sample population of Australian 
Dietitians, it was reported that under half of the participants correctly identified UVR exposure 
recommendations that promote vitamin D adequacy during winter (Dix et al., 2017). In this study, a 
quarter of the participants recommended direct sun exposure during peak UVR hours in summer for 
fair skinned individuals however (Dix et al., 2017). Furthermore, nearly a quarter of the Australian GPs 
perceived thirty minutes of direct sun exposure during peak UVR hours in summer as the length of 
time required for adequate cutaneous vitamin D synthesis (Bonevski et al., 2012). Although not 
available when the latter study was conducted, Australian guidelines recommend direct sun exposure 
for five to nine minutes, depending on location, at 10am or 2pm during summer months (Nowson et 
al., 2012). These findings suggest there is also confusion around the amount of UVR exposure that is 
required for vitamin D synthesis whilst being conscious of skin cancer risk. New Zealand GPs believed 
that a mean time of 15 minutes of direct sun exposure before 11am was sufficient in fair skinned 
individuals for cutaneous vitamin D synthesis whilst preventing sun damage (Reeder et al., 2012). At 
the time in which this study was conducted, guidelines available from the Cancer Society of New 
Zealand recommended “a few minutes” of direct sun exposure either side of the peak UVR hours in 
the summer months for this skin type (Cancer Society of New Zealand, 2007). The lack of specificity in 
this guideline means the accuracy of sun exposure recommendations made by the New Zealand GPs 




A key limitation of these studies is that the results are now irrelevant in relation to current guidelines 
in New Zealand, thus an indication of health professionals’ knowledge of safe sun exposure for vitamin 
D adequacy is unavailable. This is because sun exposure guidelines in relation to vitamin D have moved 
away from recommending specific amounts of time to be spent in the sun. Recommendations from 
the 2012 New Zealand Consensus Statement on Vitamin D have previously been outlined in this 
literature review.  
 
Similar to Bonevski et al., Reeder et al., and Dix et al., a study conducted in Israeli doctors, 
dermatologists and endocrinologists reported lack of agreement amongst professionals relating to the 
amount of time required in the sun to synthesis vitamin D (Abu-Abed, Azbarga, & Peleg, 2018). Key 
limitations of this study, however, are the small sample size of 121 participants and the greater 
potential for social desirability bias, given the survey was conducted in personal interviews and thus 
lacked anonymity (Abu-Abed et al., 2018).   
 
2.9.3 Vitamin D in Pregnancy and Infancy 
The previously discussed studies by Bonevski et al., Reeder et al., and Dix et al. have looked at health 
professionals’ knowledge of vitamin D for the general population (Bonevski et al., 2012; Dix et al., 
2017; Reeder et al., 2012; Reeder et al., 2013). In a sample of 6822 pregnant women enrolled in the 
Growing Up in New Zealand longitudinal cohort study, 98% of women engaged with a healthcare 
provider during pregnancy (Bartholomew et al., 2015). This suggests evaluation of health 
professionals’ knowledge of vitamin D for this population group and their infants is appropriate.  
 
At present however, this literature appears limited. Furthermore, current literature focuses largely on 
doctors’ knowledge. Research extending to Dietitians, Midwives and Paediatric Nurses may be 
beneficial for developing a more representative understanding of health care professionals’ 
knowledge of vitamin D for pregnancy and infancy. 
 
The research currently available focuses on health professionals’ awareness of supplementation 
guidelines (Oberhelman et al., 2018). In the three studies previously outlined, supplementation was 
the preferred method for treatment of deficiency indicated by the majority of participants (Bonevski 
et al., 2012; Dix et al., 2017; Reeder et al., 2013). Vitamin D supplementation is recommended 
prophylactically however, for at-risk pregnant women and infants (Ministry of Health, 2013a). A key 
limitation of these findings, therefore, is that they do not indicate whether health professionals are 
aware of supplement guidelines that aim to prevent deficiency. Nor does it allude to health 
professionals’ supplementation practices in infants and pregnant women.  
 
Guidelines for supplementing infants with vitamin D have been devised both nationally and 
internationally given these infants are at high risk of deficiency (Ministry of Health, 2013a; 
Oberhelman et al., 2018). In an American study of 56 physicians and nurse practitioners, 92% of the 
sample population were able to identify the correct, breastfed-infant-specific vitamin D supplement 
dose as per national paediatric guidelines. Furthermore, participants reported recommending vitamin 
D supplementation for breastfed infants 70% of the time (Oberhelman et al., 2018). These results 
suggest good knowledge of vitamin D supplementation for infants however the small sample size and 
lack of geographic spread, means these results are likely to be unrepresentative. Furthermore, given 
American guidelines were used, these results cannot be generalised to the New Zealand population 
(Oberhelman et al., 2018).  DelGiudice et al., explored physicians’ and nurse practitioners’ awareness 
of vitamin D supplementation guidelines for patients ages 18 years or younger in America. The study 
reported good awareness of risk factors for vitamin D deficiency amongst participants but a lack of 
certainty relating to prescribing vitamin D supplements (DelGiudice et al., 2018). This finding suggests 
some health professionals may be unaware of supplementation guidelines. A key limitation of this 
study, however, was the small sample size of 34 participants (DelGiudice et al., 2018).  
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A study by AlBishi et al. explored doctors’ and Well Baby nurses’ awareness of supplementation 
guidelines for infants and pregnant women in Saudi Arabia (AlBishi et al., 2018). This study reported 
that 84% of the 100 participants were aware of the association between breastfeeding and vitamin D 
deficiency in infants. Furthermore, 77% reported prescribing vitamin D supplements to exclusively 
breastfed infants as per APA guidelines (AlBishi et al., 2018). These findings suggest health 
professionals in Saudi Arabia may have good awareness of supplementation guidelines. Similar to 
previous studies discussed in this section, limitations were the small sample size and use of differing 
national guidelines (AlBishi et al., 2018). A study by Jain et al. assessed knowledge of vitamin D 
supplement guidelines in midwives, health visitors and GPs in the United Kingdom (Jain et al., 2011). 
The study reported that majority of participants were uncertain about supplementation guidelines for 
infants, pregnant and breastfeeding women, particularly in relation to patients who are high risk for 
deficiency (Jain et al., 2011). Advice regarding supplementation was given to breastfeeding women by 
45% of health visitors and 14% of GPs in this study, suggesting GPs in particular may lack knowledge 
of supplementation guidelines (Jain et al., 2011). A limitation of this study is the small sample size of 
77 health professionals.   
 
The results of these studies are conflicting, highlighting that further research is needed to develop an 
understanding of health professionals’ knowledge of vitamin D for pregnancy and infancy. 
Furthermore, the research has been conducted internationally and thus is unrepresentative of the 





Chapter 3. Research Study Manuscript 
 
3.1 Abstract 
Background: Vitamin D is now recognised as having a role in in immune system functioning and in 
protection against several complications of pregnancy and common diseases of childhood. In 2012, a 
Consensus Statement was released by the New Zealand Ministry of Health that described the 
populations who are at risk of deficiency, how to manage vitamin D status whilst being conscious of 
the harsher ultraviolet environment in New Zealand and outlined who may benefit from vitamin D 
supplementation. Furthermore in 2013, a Companion Statement was released which provided 
additional information about vitamin D specific to the pregnant, lactating and infant populations. 
These documents were designed primarily for use by health professionals. There is limited literature 
available that explores health professionals’ knowledge of vitamin D in New Zealand. International 
literature is conflicting with some studies reporting good knowledge of vitamin D deficiency risk 
factors, sun exposure guidelines and supplement guidelines while others report limited knowledge in 
these areas. International studies have reported on health professionals’ knowledge of vitamin D 
supplement guidelines for infants with conflicting results. Identifying areas where knowledge is lacking 
will help to identify where New Zealand health professionals require further education.  
 
Aims: The aim of this study is to explore health professionals’ knowledge, attitudes and current 
practices toward vitamin D for the general population, pregnancy and infancy. Furthermore, this study 
aims to explore whether knowledge and attitudes have changed between 2010 and 2019. 
 
Methods: In this ecological study, an anonymous online questionnaire was used to collect data from 
health professionals working in a profession recognised by the Health Practitioners Competence 
Assurance Act. Professionals working with pregnant women, infants and their caregivers were sought 
after in particular. This questionnaire was conducted in 2010 and in 2019 with different sample 
populations. Questions were developed in 2010 and in line with available New Zealand guidelines that 
detailed management of vitamin D status. These were the Food and Nutrition Guidelines for Healthy 
Infants and Toddlers and for Healthy Pregnant and Breastfeeding Women, and the Cancer Society 
Position Statement on the Risks and Benefits of Sun Exposure. Question types were a combination of 
multiple response sets and true or false and yes or no response options. Knowledge questions were 
forced response to avoid missing data whereas participant characteristic questions were request 
response to respect privacy. Descriptive statistics were used to analyse the results.  
 
Results: A total of 283 HPCAA-recognised health professionals completed this questionnaire (2010 
n=193; 2019 n=90). Health professionals have good knowledge of vitamin D sources, functions and 
risk factors for deficiency. There appears to be confusion surrounding the vitamin D content of 
breastmilk (44.4% in 2010 and 31.5% in 2019 selected breastmilk as a good dietary source of vitamin 
D) and exclusive breastfeeding as a risk factor for deficiency (selected by 14.6% in 2010 and 32.9% in 
2019). Knowledge of sun exposure guidelines was challenging to ascertain but results indicated a lack 
of awareness of safe sun exposure guidelines, primarily for infants. Furthermore, participants from 
both years were largely unsure about vitamin D supplement availability. Majority of participants did 
not feel there was enough information available to health professionals regarding vitamin D (81.2% in 
2010; 74.4% 2019).  
 
Conclusion: Whilst health professionals had good knowledge of deficiency risk factors, functions and 
sources of vitamin D, the study identified some knowledge deficits. Interventions to improve 
knowledge are likely to be well received as majority of participants believe there is not enough 
information available to health professionals about vitamin D. Areas where health professionals need 
further education are the vitamin D content of breastmilk, recognition of exclusive breastfeeding as a 
deficiency risk factor in infants, supplement availability and sun exposure guidelines.  
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Further studies that explore where health professionals’ source their information from regarding 
vitamin D may provide insight as to why these gaps in knowledge have occurred and how to best 
rectify them. Future studies should include larger population sizes and greater population diversity. 
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3.2 Introduction 
Traditionally, vitamin D has been recognised for its role in bone health (Pike & Christakos, 2017). The 
vitamin functions to maintain serum concentrations of calcium and phosphate by upregulating 
intestinal absorption and renal reabsorption of the two minerals (Pike & Christakos, 2017). Vitamin D 
may also stimulate resorption of these minerals from bone if necessary, as bone is a large mineral 
reservoir (Pike & Christakos, 2017). When vitamin D status is poor, and calcium and phosphate 
concentrations are low, PTH will stimulate remodelling of bone to increase serum concentration of 
the minerals (Pike & Christakos, 2017). Chronic vitamin D deficiency is therefore associated with 
weakened bone structure and more severely, bone diseases such as rickets in children and 
osteoporosis or osteomalacia in adults (Theodoratou et al., 2014).  
 
Tissues in the body that utilise vitamin D express VDR (Jablonski & Chaplin, 2018). Identification of 
VDR in tissues other than those involved in the skeletal system and calcium and phosphate 
homeostasis, has led to development of a large body of research surrounding extra-skeletal functions 
of this vitamin (Wei & Christakos, 2015). Much of this research has suggested that vitamin D may have 
a role in immune system functioning, and that implications of vitamin D deficiency may extend to risk 
of infectious diseases, autoimmune conditions and certain cancers (Wei & Christakos, 2015).  
 
New Zealand guidelines define vitamin D deficiency as serum 25(OH)D at 24nmol/L or below and 
define insufficiency as 49nmol/L or below (Ministry of Health and Cancer Society of New Zealand, 
2012). Clinical manifestations of deficiency include delayed growth, delayed standing and walking and 
frequent falling in children (Bordelon et al., 2009; Thacher & Clarke, 2011; van Schoor & Lips, 2018). 
In adults, it may present as bone pain, fractures and muscle weakness (Bordelon et al., 2009; Thacher 
& Clarke, 2011; van Schoor & Lips, 2018). Several New Zealand-based studies have reported on vitamin 
D insufficiency and deficiency in infants and toddlers. Camargo et al. reported 25(OH)D levels below 
25nmol/L in one out of every five of the 925 new-borns (Camargo et al., 2010). Houghton et al. 
identified 25(OH)D levels below 50nmol/L in 57% of the 12 to 22 month olds sampled in winter (n=55) 
(Houghton et al., 2010). Grant et al. reported that 25(OH)D levels below 27.5nmol/L were identified 
in 46 of the 353 six to 23 month olds (Grant et al., 2009). New Zealand-based studies have also 
assessed vitamin D levels in the pregnant population. Wheeler et al. reported that 25(OH)D levels 
below 50nmol/L were present in 65% of the 80 participants (Wheeler et al., 2018). Furthermore, 
Ekeroma et al. identified 25(OH)D levels below 50nmol/L in 109 of the 259 participants (Ekeroma et 
al., 2015). In a population of 2800 pregnant women from Australia and New Zealand, 25(OH)D levels 
below 50nmol/L were identified in 772 of the participants (Wilson et al., 2018).  
 
Risk factors for deficiency are largely related to sun exposure and ability to cutaneously synthesise 
vitamin D, given that UVR is the primary source (Nowson et al., 2012). Comparatively, New Zealand 
inhabitants are exposed to higher amounts of UVR secondary to ozone depletion and minimal air 
pollution (Pondicherry et al., 2018). Because of this, New Zealand has one of the highest rates of skin 
cancer internationally (Pondicherry et al., 2018). As a result, there is growing concern that strict sun 
protection messages double as a risk factor for vitamin D deficiency (Youl et al., 2009). Additional risk 
factors are ethnicity and darker skin colour, living at high latitude, season of weather and concealing 
clothing, typically those worn for cultural, religious or sun protection purposes (Ministry of Health and 
Cancer Society of New Zealand, 2012; Nowson et al., 2012). Lastly, those who are housebound, 
institutionalised or regularly spend large amounts of daylight hours inside are at greater risk of 
deficiency (Nowson et al., 2012).   
 
Pregnant women are at greater risk of vitamin D deficiency as maternal stores are relied on by the 
fetus for bone growth and development (Pludowski et al., 2013). Research has identified a possible 
association between maternal vitamin D deficiency and several complications of pregnancy including 
pre-eclampsia, GDM, PTB and birthing an infant who is SGA (Palacios et al., 2019).  
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Infants born preterm or to mothers with low vitamin D status are themselves likely to be deficient 
(Rigo & Senterre, 2006). Sun exposure guidelines for infants suggest no intentional, direct sun 
exposure at any time of the day as the immaturity of infant skin carries increased risk of skin cancer 
(Ministry of Health, 2013a; Shafie Pour et al., 2015). Dietary vitamin D is therefore the primary source 
for infants. Exclusively breastfed infants who receive minimal amounts of sun exposure are at greater 
risk of deficiency however, as breastmilk contains minimal amounts of vitamin D (Wheeler et al., 
2015). Hollis et al. reported that maternal supplementation with a daily dose of 6400IU of vitamin D 
safely increased the vitamin D status of the breastfed infant, suggesting that the vitamin D content of 
breastmilk can be improved to a level that is sufficient for meeting the infant’s vitamin D requirements 
(Hollis et al., 2015). Research is conflicting however as a New Zealand study reported that maternal 
vitamin D supplementation and dietary intake and sun exposure was not independently associated 
with breastfed infants vitamin D status (Lovell et al., 2016). Additionally, maternal supplementation 
for the purpose of increasing vitamin D content of breastmilk is not currently included in New Zealand 
guidelines (Ministry of Health, 2013a; Ministry of Health and Cancer Society of New Zealand, 2012). 
Breastmilk should therefore continue to be recognised as a poor source of vitamin D. Deficiency in 
infancy has been associated with several conditions common in childhood. These include asthma, 
respiratory tract infections, eczema and food allergies (Saggese et al., 2015).  
 
For infants and pregnant women who are at risk of deficiency, current guidelines recommend 
administering vitamin D supplements prophylactically as testing of vitamin D status is very expensive. 
These recommendations are outlined in 2012 New Zealand Consensus Statement on Vitamin D and in 
the Companion Statement that relates specifically to pregnant and lactating women and infants 
(Ministry of Health, 2013a; Ministry of Health and Cancer Society of New Zealand, 2012). These 
guidelines were developed for health professionals with the intention of providing background on the 
management of vitamin D status. As health professionals play a key role in educating the population 
about vitamin D, as well as identifying those who are at risk of deficiency and devising suitable 
management plans (Dix et al., 2017), continuing to develop an understanding of health professionals’ 
knowledge of vitamin D is justified.  
 
Current literature pertaining to health professionals’ knowledge is limited, particularly in the New 
Zealand population (Reeder et al., 2012; Reeder et al., 2013). A New Zealand-based study, which 
assessed knowledge of GPs only, was conducted prior to the release of the Consensus statement. The 
study reported moderate knowledge of deficiency risk factors and confusion around sun exposure 
guidelines. This study is limited by the fact it is now outdated, given new guidelines have since been 
released. Furthermore, this study did not assess knowledge of vitamin D relating to pregnancy and 
infancy. To the authors knowledge, no New Zealand-based studies have been conducted that explore 
health professionals’ knowledge of vitamin D for pregnancy and infancy. Additionally, there appears 
to be no New Zealand-based studies that assess health professionals’ knowledge following release of 
the Consensus and Companion Statements. In Australia, knowledge of vitamin D in GPs and Dietitians 
has been explored (Bonevski et al., 2012; Dix et al., 2017). The studies reported similar results in that 
health professionals appear to lack knowledge of sun exposure guidelines to achieve vitamin D 
adequacy in the wintertime (Bonevski et al., 2012; Dix et al., 2017). Furthermore, both studies 
reported that some health professionals were advising unsafe sun exposure practices in summer 
(Bonevski et al., 2012; Dix et al., 2017).  
 
Health professionals’ knowledge of vitamin D for infancy has been explored internationally, with 
several studies assessing awareness of vitamin D supplementation guidelines. American, Saudi 
Arabian and British studies unanimously report confusion amongst health professionals in relation to 
vitamin D supplement guidelines (AlBishi et al., 2018; DelGiudice et al., 2018; Jain et al., 2011).  
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Results have been conflicting however, as an American study reported good awareness of their 
relevant national guidelines (Oberhelman et al., 2018). Research related to health professionals’ 
knowledge of vitamin D for pregnancy does not appear to be available.  
 
This study aims to build on current literature that explores health professionals’ knowledge and 
attitudes toward vitamin D for pregnancy and infancy. Data may be used to identify gaps in knowledge 




3.3.1 Ethical Approval  
Request for ethical approval of this study was sent to the Massey University Human Ethics Committee. 
This study received a low risk notification.  
 
3.3.2 Questionnaire Design 
In this ecological study, an online questionnaire was used to collect data via SurveyMonkey, an online 
questionnaire development software, from New Zealand health professionals. This questionnaire was 
conducted in both 2010 and 2019 with different sample populations of New Zealand health 
professionals so that change in knowledge could be observed. The questionnaire was composed of 41 
questions and took approximately nine minutes to complete according to SurveyMonkey analytics.  
 
The questionnaire was composed of six sections. Aspects of vitamin D knowledge and status 
management were categorised into the following; general knowledge of vitamin D, awareness of 
current recommendations, knowledge of vitamin D and sun exposure in the New Zealand context, and 
current practices regarding management of vitamin D status. Questions were developed in 2010. 
These were based on comprehensive literature search, the Cancer Society of New Zealand’s Position 
Statement on the Risks and Benefits of Sun Exposure in New Zealand (Cancer Society of New Zealand, 
2007) and on Food and Nutrition Guidelines for both Healthy Infants and Toddlers (Ministry of Health, 
2008a) and Healthy Pregnant and Breastfeeding Women (Ministry of Health, 2006a). The same 
questionnaire was administered to the 2010 and 2019 sample populations. This allowed exact 
comparison of questionnaire responses between the two time points. Furthermore, this gave a better 
representation of knowledge improvement following release of the Consensus Statement.  
 
Questions were forced response to avoid missing data (Albaum, Roster, Wiley, Rossiter, & Smith, 
2010) however those pertaining to participant characteristics were request response to respect 
privacy. The response set within forced response questions typically gave participants the option to 
select unsure. Question types were a combination of multiple response sets and true or false and yes 
or no response options. 
 
The questionnaire was pilot tested in a group of health professionals to assess readability, 
understanding, and relevance of content.  
 
3.3.3 Recruitment 
Participants in the 2010 cohort were recruited via invitation distributed to health professionals listed 
in Massey University’s contact database. Primary researchers in 2010 forwarded invitations to 
complete the questionnaire to personal contacts in the healthcare workforce.  
 
Invitations to participate (appendix C.1) in the 2019 study were sent to several relevant organisations 
including Dietitians New Zealand, New Zealand Nurses Organisation, Plunket and New Zealand College 
of Midwives.  
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Furthermore, invitations were sent to health professionals listed in Massey University’s contact 
database. Dietitians New Zealand and New Zealand Nurses Organisation permitted the questionnaire 
to be posted on their closed Facebook groups with memberships of 718 and approximately 8200 
respectively. Plunket’s Population Health Advisor distributed the online questionnaire invitation via 
email to their database of registered nurses whom they employ. The governance group from New 
Zealand College of Midwives were unable to review and distribute the questionnaire invitation within 
a suitable timeframe for this study. Invitations were sent to Silverdale medical centre, Apollo medical 
centre, Massey University Health Centre and Alliance Health PHO.  
 
Upon completion of the questionnaire, participants were provided with the questionnaire access 
weblink which they were encouraged to forward to colleagues. Response rate was not able to be 
calculated given the anonymity and varying routes of distribution, particularly where access to 
databases were not provided to the primary researcher.  
 
The information sheet was provided in the preface of the questionnaire. Completion of the 
questionnaire indicated consent for data to be used for the purpose of this study. Participants 
remained anonymous however had the opportunity to provide contact details should they want to 




In line with the aim of the study, questionnaire respondents were excluded if they did not indicate 
employment and/or holding an approved qualification required to practice as a health professional. 
Health professions included in this study were limited to those recognised by the Health Practitioners 
Competence Assurance Act (HPCAA) (Ministry of Health, 2020) as this provides a practical channel for 
delivering interventions to improve knowledge level. Plunket Nurse was offered as an additional 
employment response to Nurse. Specifying this profession allowed more in-depth statistical analysis 
of knowledge in professionals who are likely to be interacting with the pregnant and infant population.  
 
Aside from incomplete questionnaire response, no further inclusion or exclusion criteria were defined. 
Specific criteria such as age, spoken language, location within New Zealand and years of practice were 
not deemed necessary for improving research quality as a diverse sample population may help to 
improve representativeness. Ethnicity was prioritised as per Ministry of Health guidelines (Ministry of 
Health, 2008b). A filter was set in SurveyMonkey that removed participants without a 75% completion 
rate. Completion rate was calculated manually for hard-copy data.    
 
The sample size of the 2010 population was determined by the number of survey responses that met 
inclusion criteria. For the 2019 population, sample size was restricted by limited recruitment time due 
to a strict timeframe for competition of the project.  
 
3.3.5 Data Handling and Statistical Analysis  
Additional, hard-copy data were collected from the 2010 study population and uploaded to 
SurveyMonkey. Data collected in 2019 were solely electronic. Data from both sample populations 
were exported into Microsoft Excel for cleaning.  
 
Cleaned data were uploaded to IBM SPSS Statistics software package for Windows (version 24). 
Response proportions were presented as percentages. Where data were missing in single response 
sets, valid percentage was presented as this value did not include missing cases. Where this has 
occurred, response n is not equal to sample size n in some instances, as missing cases were not 
included. Multiple response sets were presented as percentage of cases thus totals do not add up to 
100%. Years of experience data were tested for normality using Kolmogorov-Smirnov and Shapiro-
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Wilk tests with significance set at 0.05 or below. Abnormal data were log transformed and re-tested 




3.4.1 Participant Characteristics  
Responses from 283 health professionals were used in this study. From the year 2010, 193 participants 
met the inclusion criteria and from the year 2019, 90 participants were suitable for inclusion. A total 
of 31 participants were excluded from the study due to unsuitable or lack of occupation selected; 19 
in the year 2019 and 12 in the year 2010.   
 
Within both cohorts, the majority of the participants were female (95.9% in 2010 and 98.9% in 2019) 
and of New Zealand European ethnicity (75.3% in 2010 and 2019). In 2010, nurse was the most 
common occupation (51.3%) whereas dietitian (28.9%) was more common in 2019. Midwives were 
the least represented occupation in 2010 (5.2%) whereas GPs were the least represented in 2019 
(2.2%). Median (25th, 75th percentile) years of experience decreased between the two populations; in 
2010 it was 15 (5, 27.5) compared to 8 (4, 16.7) in 2019. Participant characteristics data is summarised 
in table 3.1.  
 
Table 3.1 Participant Characteristics     
 2010 n=193 2019 n=90 
 n (%) n (%) 
Gender 
Female 185 (95.9) 88 (98.9) 
Male 8 (4.1) 1 (1.1) 
Ethnicity 
NZ European 143 (75.3) 67 (75.3) 
Māori 21 (11.1) 7 (7.9)  
Pacific Islander 6 (3.2) 0 
Chinese 3 (1.6) 1 (1.1) 
Indian 4 (2.1) 2 (2.2) 
Other 13 (6.8) 12 (13.5) 
Occupation 
Dietitian 28 (14.5) 26 (28.9) 
Midwife 10 (5.2) 22 (24.4) 
General Medical Practitioner 15 (7.8) 2 (2.2) 
Nurse 99 (51.3) 10 (11.1) 
Plunket Nurse 32 (16.6) 23 (25.6) 
Other 9 (4.7) 7 (7.8) 
Type of work establishment +  
Hospital based 21 (13.8) 25 (30.1) 
Community based 46 (30.3) 31 (37.3) 
Plunket clinic 35 (23.0) 18 (21.7) 
Medical centre 49 (32.2) 2 (2.4) 
Private practice 15 (9.9) 7 (8.4) 




3.4.2 Knowledge of Vitamin D Sources and Functions  
In both populations, 94% of participants selected manufactured in the skin as the most important 
source of vitamin D. Of the food source response options, the most commonly selected by 2010 
participants were infant or toddler formula (68.6%), oily fish (67%), and fortified cow’s milk (53.5%). 
In 2019, the most commonly selected were slightly different and included oily fish (79.8%), eggs 
(61.8%) and fortified cow’s milk (61.8%). In both populations, over one third of participants selected 
breast milk as a good dietary source (44.3% and 31.5% in 2010 and 2019 respectively). These results 
are summarised in table 3.2.  
 
Table 3.2 Knowledge of Vitamin D Sources  
 2010 n (%) 2019 n (%) 
What do you think is the single most important source of vitamin D for average New 
Zealanders? 
Manufactured in the skin 183 (94.8) 85 (94.4) 
Natural food sources 5 (2.6) 4 (4.4) 
Fortified food products 2 (1.0) 0  
Other 2 (1.0) 1 (1.1) 
Don’t know 1 (0.5) 0 
Which of the following are good dietary sources of vitamin D? + 
Grapes 13 (7.0) 1 (1.1 
Oily fish e.g. canned tuna, 
sardines or salmon 
124 (67.0) 71 (79.8) 
Cow’s milk (unfortified) 37 (20.0) 19 (21.3) 
Eggs 82 (44.3) 55 (61.8) 
Infant or toddler formula 127 (68.6) 48 (53.9) 
Red meat 29 (15.7) 6 (6.7) 
Bread 15 (8.1) 0  
Fish oil 89 (48.1) 39 (43.8) 
Breast milk 82 (44.3) 28 (31.5) 
Fortified cow’s milk 99 (53.5) 55 (61.8) 
Liver 53 (28.6) 34 (38.2) 
+ Multiple response set, participants able to select more than one answer. 
 
Table 3.3 provides a summary of the health professionals’ knowledge of vitamin D functions. In both 
populations, almost all selected aiding with the absorption of calcium (82.9% and 90% in 2010 and 
2019 respectively) and needed for bone development and mineralisation (80.3% and 94.4% in 2010 
and 2019 respectively) when asked to select the functions of vitamin D. The proportion of those who 
selected aiding with immune system function increased between 2010 (38.3%) and 2019 (72.2%). 
Furthermore, in both populations almost all selected rickets (86.3% and 84.4% in 2010 and 2019 
respectively) and osteoporosis (82.1% and 85.6% in 2010 and 2019 respectively) as diseases 
associated with low levels of vitamin D.  
  
 33 
Table 3.3 Knowledge of Vitamin D Function 
 2010 n (%) 2019 n (%) 
What are the roles of Vitamin D in the body? + 
Aids with the absorption of 
calcium 
160 (82.9) 81 (90) 
Vitamin D is an antioxidant 44 (22.8) 18 (20) 
Vitamin D is needed for bone 
development and 
mineralisation 
155 (80.3) 85 (94.4) 
Vitamin D aids with immune 
system function 
74 (38.3) 65 (72.2) 
Vitamin D is needed for blood 
clotting 
20 (10.4) 13 (14.4) 
Which of the disease states listed below are associated with low levels of vitamin D? + 
Breast Cancer 26 (13.7) 15 (16.7) 
Prostate Cancer 18 (9.5) 13 (14.4) 
Skin Cancer 21 (11.1) 12 (13.3) 
Type 1 Diabetes 14 (7.4) 17 (18.9) 
Inflammatory Bowel Disease 26 (13.7) 18 (20.0) 
Multiple Sclerosis 29 (15.3) 21 (23.3) 
Rheumatoid Arthritis 33 (17.4) 22 (24.2) 
Depression  99 (52.1) 66 (73.3) 
Renal Disease 22 (11.6) 11 (12.2) 
Gallstones 7 (3.7) 5 (5.6) 
Heart Disease 19 (10.0) 13 (14.4) 
Rickets 164 (86.3) 76 (84.4) 
Osteoporosis 156 (82.1) 77 (85.6) 
+ Multiple response set, participants able to select more than one answer. 
 
3.4.3 Knowledge and Attitudes Toward Sun Exposure 
A large proportion of the 2010 (78.5%) and the 2019 (73.3%) participants believed that skin cancer 
messages make it difficult to get messages about vitamin D across. When asked to identify the correct 
time period in which time should be spent in the sun during summer, the 2010 participants more 
commonly selected before 11am and after 4pm (64.8%) whereas the 2019 participants more 
commonly selected before 10am and after 2pm (68.9%). The proportion of participants who selected 
before 12pm and after 5pm increased from 1.1% in 2010 to 20% in 2019. A larger proportion of the 
2019 participants (78.9%) believed people with dark skin need to spend longer in the sun to synthesis 
adequate vitamin D compared to the 2010 participants (53.9%). With regards to sunlight exposure 
through a window, similar proportions of the 2010 and 2019 participants believed this was not safer 
than outdoor sun exposure (60.1% and 612.2% respectively). Furthermore, similar proportions 
indicated this method was not as effective as outdoor sun exposure in relation to vitamin D synthesis 
(47.2% and 52.2% in 2010 and 2019 respectively).  
 
In 2019, a larger proportion of participants believed that people living in the South Island of New 
Zealand were at more risk of deficiency in 2019 (72.2%) compared to 2010 (46.1%). In 2010, 73% of 
participants believed season affects the amount of time required in the sun to synthesise vitamin D. 
A further 81.3% believed that vitamin D status may drop below adequate levels in winter. The results 
were similar in the 2019 population with 87.8% believing the effect of season and a further 91.1% 




Table 3.4 Knowledge and Attitudes Toward Sun Exposure Guidelines 
 2010 n (%) 2019 n (%) 
Skin cancer messages make it difficult to get messages about vitamin D across 
True 150 (78.5) 66 (73.3) 
False 28 (14.7) 14 (15.6) 
Unsure 13 (6.8) 10 (11.1) 
During which times in summer should time be spent in the sun to allow synthesis of vitamin D? 
Before 11am and after 4pm 118 (64.8) 4 (4.4) 
Before 10am and after 2pm 44 (24.2) 62 (68.9) 
Before 12pm and after 5pm 2 (1.1) 18 (20.0) 
Unsure 18 (9.9)  6 (6.7) 
People with dark skin e.g. Māori and Pacific Island people need to spend longer in the sun to 
synthesise adequate vitamin D 
True 104 (53.9) 71 (78.9) 
False 50 (25.9) 11 (12.2) 
Unsure 39 (20.2) 8 (8.9) 
Exposure to sunlight through a window is safer than outdoor sun exposure 
True 37 (19.2) 15 (16.7) 
False 116 (60.1) 56 (62.2) 
Unsure 40 (20.7) 19 (21.1) 
Exposure to sunlight through a window is just as effective as outdoor sun exposure in relation 
to vitamin D synthesis 
True 52 (26.9) 11 (12.2) 
False 91 (47.2) 47 (52.2) 
Unsure 50 (25.9) 32 (35.6) 
People living in the South Island of New Zealand are more at risk of vitamin D deficiency 
True 89 (46.1) 65 (72.2) 
False 64 (33.2) 7 (7.8) 
Unsure 40 (20.7) 18 (20.0) 
Season affects the amount of time needed in the sun to synthesise adequate vitamin D  
True 142 (73.6) 79 (87.8) 
False 27 (14.0) 6 (6.7) 
Unsure 24 (12.4) 5 (5.6) 
During winter vitamin D status may drop below adequate levels 
True 157 (81.3) 82 (91.1) 
False 12 (6.2) 1 (1.1) 
Unsure 24 (12.4) 7 (7.8) 
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3.4.4 Pregnancy and Infancy  
The most common advice that health professionals in this study indicated should be given to parents 
when discussing sun exposure for infants and toddlers varied by year. In 2010, 85.5% selected sun 
protection measures should be followed between 11am and 4pm followed by 64.8% selecting 
excessive sun exposure can lead to increased risk of skin cancer. In 2019, 51.2% selected the former 
and 84.4% selected the latter.  
 
When asked about sun exposure guidelines for infants and their mothers, 57.8% of the 2010 
population and 46.5% of the 2019 population believed parents are recommended to expose baby’s 
face and arms for five to ten minutes, dependent on skin colour, of direct sunlight per day before 
11am and after 4pm during summer. With regards to sun exposure for infants during winter and 
spring, 86% of the 2010 population and 88.9% of the 2019 population believed this was necessary to 
maintain adequate vitamin D levels.  
 
Similar proportions of health professionals in this study believed that pregnant and lactating women 
are recommended to expose their face and arms to 20 minutes of sunshine per day between October 
and March with 55.4% selecting true in 2010 and 52.2% selecting true in 2019. Similar proportions 
believed that deliberate sun exposure during peak UV time was not recommended for pregnant and 
lactating women (75.6% and 73.3% in 2010 and 2019 respectively). Lastly, similar proportions believed 
that most pregnant women will achieve adequate vitamin D status in summer through incidental sun 
exposure outside of peak UV times (53.4% in 2010 and 55.6% in 2019). When asked whether there is 
enough information about vitamin D available to parents, majority of the participants selected no 
(95.2% and 94.4% in 2010 and 2019 respectively). A summary of these findings can be found in table 
3.5. 
 
When asked about supplement availability in New Zealand, 41.6% of the 2010 population indicated 
awareness of supplements for infants and toddlers compared to 55.6% of the 2019 population. With 
regards to supplements available specifically for pregnant women, 37.8% of the 2010 population 
believed there were supplements available that contained vitamin D compared to 40% of the 2019 
population. The most commonly selected recommendation regarding indication for vitamin D 
supplementation in infants and toddlers for both populations was only infants and toddlers at risk of 
deficiency require supplementation (57.1% and 80% in 2010 and 2019 respectively). In 2010, 29.8% 
of participants indicated they were unsure about the recommendation compared to 8.9% in the 2019 
population. Table 3.6 provides a summary of these results.  
 
The most commonly selected risk factors for vitamin D deficiency in pregnancy and lactation were 
being housebound in both 2010 (80.2%) and in 2019 (94.3%). This was followed by covering the skin 
for cultural or religious reasons in both 2010 (88.8%) and in 2019 (94.3%). Dark skin was selected by 
49.2% in 2010 and by 89.9% in 2019. The proportion who selected living in the South Island of New 
Zealand increased from 33.2% in 2010 to 78.4% in 2019. For infants, the most commonly selected risk 
factor was irregular sunlight exposure in both 2010 (89.2%) and 2019 (97.8). Exclusive breastfeeding 
was selected by 14.6% in 2010 and 32.9% in 2019. Covering the skin was selected by 72.4% of the 
2010 population and by 86.5% of the 2019 population. Prematurity and maternal deficiency were 
selected by 45.4% and 65.4% respectively in 2010; in 2019, the proportions increased to 64% and 




Table 3.5 Awareness of Guidelines for Infants and Pregnant Women 
 2010 n (%) 2019 n (%) 
What advice should be given to a parent when discussing sun exposure for infants and toddlers 
in relation to vitamin D? + 
Sun protection measures (e.g. 
wearing a hat, wearing sun 
block, seeking shade) should 
be followed between 11am 
and 4pm 
165 (85.5) 86 (51.2)  
Only expose your baby 
through a window 
8 (4.1) 5 (5.6) 
Only expose your baby to sun 
while he/she is being 
exclusively breast fed 
5 (2.6) 1 (1.1) 
Excessive sun exposure can 
lead to increased risk of skin 
cancer 
 125 (64.8) 76 (84.4) 
None of the above 16 (8.3) 0 
In summer, parents are recommended to expose baby’s face and arms to 5 (for light skin) to 20 
minutes (for dark skin) of direct sunlight per day before 11am and after 4pm 
True 111 (57.8) 41 (46.5) 
False 24 (12.5) 10 (11.1) 
Unsure 57 (29.7) 39 (43.3) 
During winter and spring, infant and toddlers should spend time outside in the sun to maintain 
adequate vitamin D levels 
True 166 (86.0) 80 (88.9) 
False 6 (3.1) 2 (2.2) 
Unsure 21 (10.9) 8 (8.9) 
Between October and March pregnant and lactating women are recommended to expose their 
face and arms to 5-20 minutes of sunshine per day 
True 107 (55.4) 47 (52.2) 
False 21 (10.9) 7 (7.8) 
Unsure 65 (33.7) 36 (40.0) 
Deliberate sun exposure during peak UV times is recommended for pregnant and lactating 
women 
True 17 (8.8) 5 (5.6) 
False 146 (75.6) 66 (73.3) 
Unsure 30 (15.5) 19 (21.2) 
Most pregnant women will achieve adequate vitamin D status in summer through incidental 
sun exposure outside peak UV times 
True 103 (53.4) 50 (55.6) 
False 41 (21.2) 19 (21.1) 
Unsure 49 (25.4) 21 (23.3) 
Is there enough information about vitamin D available for parents? 
Yes 9 (4.8) 5 (5.6) 
No 179 (95.2) 84 (94.4) 
+ Multiple response set, participants able to select more than one answer.  
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Table 3.6 Awareness of Supplements for Infants and Pregnant Women 
 2010 n (%) 2019 n (%) 
Are you aware of any Vitamin D supplements for infant and toddlers available in New Zealand? 
Yes 79 (41.6) 50 (55.6) 
No 111 (58.4) 40 (44.4) 
Do any of the multiple vitamin and mineral supplements designed for women to take during 
pregnancy contain vitamin D? 
Yes 73 (37.8) 36 (40.0) 
No 8 (4.1) 2 (2.2) 
Unsure 112 (58.0) 52 (57.8) 
What is the current recommendation regarding vitamin D supplementation in infants and 
toddlers? + 
All exclusively breastfed 
infants require vitamin D 
supplementation 
11 (5.8) 10 (11.1) 
All formula fed infants require 
vitamin D supplementation  
20 (10.5) 3 (3.3) 
Only infants and toddlers at 
risk of deficiency may require 
vitamin D supplementation 
109 (57.1) 72 (80.0) 
No New Zealand infants or 
toddlers require vitamin D 
supplementation 
 11 (5.8) 3 (3.3) 
Unsure 57 (29.8) 8 (8.9) 
+ Multiple response set, participants able to select more than one answer. 
 
Table 3.7 Knowledge of Risk Factors for Deficiency During Pregnancy and Infancy 
 2010 n (%) 2019 n (%) 
Which of the following are risk factors for vitamin D deficiency during pregnancy and lactation? 
Exclusion of dairy products 74 (39.6) 42 (47.7) 
Dark skin 92 (49.2) 79 (89.8) 
Being housebound 150 (80.2) 83 (94.3) 
Having multiple pregnancies 51 (27.3) 43 (48.9) 
Living in the South Island of 
New Zealand 
62 (33.2) 69 (78.4) 
Covering the skin for cultural 
or religious regions 
166 (88.8) 63 (94.3) 
Which of the following are risk factors for vitamin D deficiency during infancy and childhood? 
Dark skin 100 (54.1) 75 (84.3) 
Covering the skin 134 (72.4) 77 (86.5) 
Being born prematurely 84 (45.4)  57 (64.0) 
Gender 11 (5.9) 8 (9.0) 
Having a mother who is 
vitamin D deficient 
121 (65.4) 63 (70.8) 
Not being regularly exposed to 
sunlight 
165 (89.2) 87 (97.8) 
Exclusive breastfeeding 27 (14.6) 29 (32.9) 
Formula feeding 5 (2.7) 11 (12.4) 
Born high birthweight  4 (2.2) 9 (10.1) 
+ Multiple response set, participants able to select more than one answer.  
 38 
3.5.4 Current Practices  
The most common advice that health professionals in the 2019 population indicated they would give 
if concerned about vitamin D deficiency in a pregnant woman, was to increase sun exposure (67.9%). 
In the 2010 population, the most commonly selected response to this question was I do not give advice 
on vitamin D deficiency (67.9%) followed by increased sun exposure (51.1%). In 2019, 21.8% reported 
not giving advice to pregnant women.  
 
The results for advice relating to vitamin D deficiency in an infant or toddler mirrored the results for 
in pregnant women. In 2010, the most common response was I do not give advice (52.5%) followed 
by increased sun exposure (51.4%). In 2019, the most common answer was increased sun exposure 
(62.4%). The proportion of participants who selected take a vitamin D supplement in response to this 
question increased between 2010 and 2019 for both pregnant women (18.9% and 61.5% in 2010 and 
2019 respectively) and infants and toddlers (9.3% and 38.8% in 2010 and 2019 respectively).  
 
Participants did not appear confident in recognising the signs of deficiency in infants and children as 
84.5% of the 2010 population selected no I do not feel confident followed by 85.6% of the 2019 
population.  
 
In 2010, 68.2% of participants were concerned that some of their patients may be vitamin D deficient; 
in the 2019 population, this proportion was slightly greater at 73.3%. When asked about the number 
of suspected cases, the most common response was zero in both populations (61.2% and 55.6% in 
2010 and 2019 respectively). In 2010, 12.2% of participants reported encountering over five cases 
compared to 17.8% in 2019. Number of cases was not significantly associated with profession. In 2010, 
5.2% of these cases were self-managed by the health professional compared to 17.2% referring on to 
a specialist or hospital. In 2019, 26.3% were self-managed compared to 55.3% being referred to a 
specialist.  
 
Information available to health professionals was deemed to be not enough by 81.2% of the 2010 
population and 74.4% of the 2019 population. These findings have been summarised in table 3.8.  
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Table 3.8 Current Practices  
 2010 n (%) 2019 n (%) 
If you were concerned about vitamin D deficiency in a pregnant woman what advice would you 
give? + 
I don’t give advice on vitamin 
D deficiency  
129 (67.9) 17 (21.8) 
Take a vitamin D supplement 36 (18.9) 48 (61.5) 
Increased intake of foods 
which are good sources of 
vitamin D  
86 (45.3) 47 (60.3) 
Increased sun exposure 97 (51.1) 53 (67.9) 
To take cod liver oil capsules 17 (8.9) 7 (9.0) 
Refer to a specialist 64 (33.7) 21 (26.9) 
Don’t know 18 (9.5) 6 (7.7) 
If you were concerned about vitamin D deficiency in a baby/child what advice would you give? + 
I don’t give advice on vitamin 
D deficiency  
96 (52.5) 18 (21.2) 
Take a vitamin D supplement 17 (9.3) 33 (38.8) 
Increased intake of foods 
which are good sources of 
vitamin D  
89 (48.6) 40 (47.1) 
Increased sun exposure 94 (51.4) 53 (62.4) 
To take cod liver oil capsules 16 (8.7) 10 (11.8) 
Refer to a specialist 74 (40.4) 30 (35.3) 
Don’t know 20 (10.9) 7 (8.2) 
Do you feel confident that you would recognise the signs and symptoms of vitamin D deficiency 
in infants and toddlers? 
Yes 30 (15.5) 13 (14.4) 
No 163 (84.5) 77 (85.6) 
Are you concerned that some of your clients/patients may be vitamin D deficient? 
Yes 131 (68.2) 66 (73.3) 
No 44 (22.9) 12 (13.3) 
Not relevant 17 (12.4) 12 (13.3) 
How many suspected or actual cases of vitamin D deficiency have you encountered over the 
past 5 years? 
None 115 (61.2) 50 (55.6) 
1-2 36 (19.1) 18 (20.0) 
3-5 14 (7.4) 6 (6.7) 
>5 23 (12.2) 16 (17.8) 
How were these cases managed? 
Not applicable 112 (58.3) 11 (14.5) 
Provided all the management 
myself 
10 (5.2) 20 (26.3) 
Referred to specialist/hospital 33 (17.2) 42 (55.3) 
Other 37 (19.3) 3 (3.9) 
Do you think there is enough information about vitamin D available for health professionals? 
Yes 36 (18.8) 23 (25.6) 
No 155 (81.2) 67 (74.4) 
+ Multiple response set, participants able to select more than one answer.  
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3.5 Discussion 
This study explores health professionals’ knowledge and attitudes toward vitamin D for pregnancy 
and infancy in 2010 and 2019. The results indicate a varying level of understanding relating to vitamin 
D general knowledge, current recommendations for infants and pregnant women, and sun exposure 
guidelines. Although there appears to be an improvement in knowledge since 2010, there are still 
some important gaps, especially regarding the vitamin D contribution of breast milk, supplements, 
and sun exposure recommendations for infants. In both year groups, majority of participants were in 
agreement that there is insufficient information about vitamin D available to health professionals and 
parents.   
 
3.5.1 Participant Characteristics 
Females were largely overrepresented in both year groups. This finding is similar to that of an 
Australian study conducted by Dix et al. addressing knowledge of vitamin D in dietitians (Dix et al., 
2017). An explanation for this overrepresentation in the latter study, is that the Australian dietetic 
workforce is largely female-dominated (Brown, Capra, & Williams, 2006). Additionally, New Zealand 
European ethnicity was overrepresented in both year groups, a finding similar to that of a New 
Zealand-based study conducted by Reeder et al. of health professionals’ knowledge (Reeder et al., 
2013). The limited representation of Māori and Pacific in the present study is similar to findings 
presented in a report by The New Zealand Health Workforce Advisory Committee. Māori and Pacific 
practitioners were reported to make up five and 1.7% of the professional health workforce 
respectively (Health Workforce Advisory Committee, 2010).  
 
3.5.2 Knowledge of Vitamin D Sources and Functions 
Similar proportions of participants in 2010 (94.8%) and 2019 (94.4%) correctly identified the primary 
source of vitamin D as being manufactured in the skin. This finding is similar to the New Zealand-based 
knowledge study where 91% of participants identified sun exposure outdoors as the main source of 
vitamin D (Reeder et al., 2013).  
 
Selection of good dietary sources of vitamin D varied between year group with infant or toddler 
formula being the most frequently selected in 2010 (68.6%) and oily fish being more frequently 
selected in 2019 (79.8%). Both items are suitable food sources of vitamin D, relevant to different 
populations (Ministry of Health, 2013a; Ministry of Health and Cancer Society of New Zealand, 2012). 
Knowledge of food sources was assessed by Dix et al.; the results of this study were similar to data 
from the 2019 participants with oily fish being selected by 85% of participants (Dix et al., 2017). A 
concerning finding however, was that breastmilk was selected as a good dietary source of vitamin D 
in both year groups (44.3% and 31.5% in 2010 and 2019 respectively). Frequency of selection 
decreased between population however suggesting that awareness of the low vitamin D 
concentration of breastmilk, may have improved over time with release of the Consensus and 
Companion Statements. Breastmilk is the preferred food source for infants as per Ministry of Health 
guidelines (Ministry of Health, 2008a); it is possible that public health messages pertaining to the 
nutritional completeness of breastmilk, have led to confusion about vitamin D content. Furthermore, 
evidence is available that suggests maternal supplementation with vitamin D increases the vitamin D 
concentration of breastmilk to an acceptable level (Dawodu & Tsang, 2012). In a 2006 pilot RCT, Hollis 
et al. demonstrated that a daily 6400IU vitamin D supplement taken by lactating women was effective 
in raising serum vitamin D concentration in their breastfeeding infant (Wagner, Hulsey, Fanning, 
Ebeling, & Hollis, 2006). Infants in the study whose mothers did not receive a vitamin D-containing 
supplement, themselves received a 300IU daily vitamin D supplement (Wagner et al., 2006). The rise 
in serum vitamin D in infants of supplemented mothers was equivalent to the rise in serum vitamin D 
observed in the infants who received a 300IU supplement (Wagner et al., 2006). A limitation of this 
study was the small sample size of 19 women.  
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A more recent 2015 RCT conducted by Hollis et al. with a sample size of 334 mother-infant pairs, 
reported that a daily vitamin D supplement of 6400IU taken by the mother increased the vitamin D 
content of their breastmilk to meet the vitamin D requirements of the infants without harmful side 
effects (Hollis et al., 2015). Similar to the pilot RCT, maternal vitamin D supplementation of 6400IU 
per day raised the breastfed infants’ vitamin D level equivalent to infant vitamin D supplementation 
of 400IU per day (Hollis et al., 2015). These findings highlight that breastmilk has the potential to be a 
good dietary source of vitamin D, when the lactating mother is replete. Awareness of this research 
may have contributed to professionals’ selection of this response. it is important that New Zealand 
health professionals remain aware of the limited contribution breastmilk makes to the infants’ vitamin 
D status given that the vitamin D concentration of breastmilk is improved when mothers are 
supplemented in much larger doses than the monthly 50,000IU currently subsidised in New Zealand. 
Maternal supplementation and subsequent changes in breastmilk vitamin D concentration have been 
explored in the New Zealand population. Lovell et al. reported that the serum vitamin D concentration 
in exclusively breastfed infants was independent of maternal supplementation, dietary intake and sun 
exposure (Lovell et al., 2016). Additionally, a study by Hougton et al. of 193 infants and toddlers 
reported that breastfeeding was independently associated with lower infant and toddler 25(OH)D 
levels (Houghton et al., 2010). A study by Grant et al. of 353 infants and toddlers reported that 
duration of breastfeeding was not associated with risk of vitamin D deficiency in the infant or toddler, 
however risk was increased in those who had never received milk formula (Grant et al., 2009). These 
findings further support that New Zealand health professionals must remain aware of the typically low 
vitamin D concentration of breastmilk. With the exception of breastmilk, health professionals in both 
year groups appeared to have good knowledge of vitamin D food sources as all appropriate answers 
were selected.  
 
Majority of participants from both year groups correctly selected the functions of vitamin D as aiding 
in the absorption of calcium (82.9% and 90% in 2010 and 2019 respectively) and needed for bone 
development and mineralisation (80.3% and 94.4% in 2010 and 2019 respectively). This result was 
similar to those identified by Dix et al. where 95% selected calcium absorption and 95% selected bone 
development and mineralisation (Dix et al., 2017). In the present study, a much larger proportion of 
participants in 2019 selected aiding with immune system functioning (72.2% in 2019 compared to 
38.3% in 2010).  The increased frequency of selection in 2019 may be a result of vitamin D’s role in 
immunity receiving greater research attention over the past decade. Dix et al. reported that immune 
system functioning was selected by 58% of participants (Dix et al., 2017). Majority of participants from 
both year groups correctly and most frequently selected rickets (86.3% and 84.4% in 2010 and 2019 
respectively) and osteoporosis (82.1% and 85.6% in 2010 and 2019 respectively) as diseases 
associated with low levels of vitamin D. Similar results were observed by Dix et al. where 96% selected 
osteoporosis and 80% selected rickets (Dix et al., 2017).  
 
3.5.3 Knowledge and Attitudes Toward Sun Exposure 
Across the year groups, participants shared a similar attitude toward sun exposure messages making 
it difficult to get messages about vitamin D across. Both cohorts reported that public health messages 
about skin cancer risk made it difficult to communicate the important of vitamin D (78.5% in 2010 and 
73.3% in 2019). Bonevski et al. reported similar results with 67.7% of participants agreeing that skin 
cancer prevention messages contribute to development of vitamin D deficiency (Bonevski et al., 2012). 
Reeder et al. reported that patient request for information regarding the use of sun protection and its 
impact on vitamin D was reported as one of the most vitamin D-related patient enquiries.   
 
Knowledge of appropriate times in summer when time should be spent in the sun varied by year 
group. In 2010, the most frequently selected option was before 11am and after 4pm. Based on sun 
guidelines available at the time, this timeframe was correct (Cancer Society of New Zealand, 2007).  
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In 2019, the most frequently selected option was before 10am and after 2pm. Again, depending on 
guideline used, this timeframe is now correct. According to the Australian and New Zealand Bone 
Mineral Society Position Statement on Vitamin D in Health in Adults, before 10am and after 2pm are 
safe times for direct sun exposure to ensure adequate synthesis of vitamin D. The 2012 New Zealand 
Consensus Statement on Vitamin D states that direct sun exposure before 10am and after 4pm is 
safer; the questionnaire did not offer this timeframe, however. Overall, knowledge of suitable 
timeframes for sun exposure appeared good. Furthermore, knowledge appeared to shift with release 
of new guidelines. Concerning however, is that the proportion of participants who selected before 
12pm and after 5pm increased between 2010 (1.15) and 2019 (20%) despite release of new guidelines. 
This is concerning as UVR becomes potentially damaging from 10am onwards (National Institute of 
Water and Atmospheric Rsearch, 2020). Reeder et al. reported that 35% of participants recommended 
daily sun exposure during peak UVR times of the day as a method for preventing vitamin D deficiency, 
without reference to season (Reeder et al., 2013). It is possible that the findings of Reeder et al. 
support the present study in that there is some confusion amongst health professionals relating to 
sun exposure guidelines.  
 
A larger number of participants in 2019 (78.9%) compared to 2010 (53.9%), believed that people with 
dark skin such as Māori and Pacifica needed to spend longer amounts of time in the sun to synthesise 
adequate vitamin D.  This finding suggests that awareness of skin colour and its impact on vitamin D 
status has improved. However, different guidelines state different recommendations. The Consensus 
Statement acknowledges dark skin as a deficiency risk factor but does not advocate for longer periods 
of sun exposure for this skin type. A similar guideline was presented in the outdated Cancer Society 
Position Statement. The Australian New Zealand Bone Mineral Society Position Statement suggests 
that individuals with dark skin may need to spend six to seven times longer in the sun to synthesis 
adequate vitamin D compared to their fairer skinned counterparts. Given the sun protective nature of 
melanin, darker skinned individuals are likely to need longer in the sun to synthesise adequate vitamin 
D (Webb et al., 2018). Ethnicity is typically used to associate skin tone in past and current New Zealand 
guidelines (Cancer Society of New Zealand, 2007; Ministry of Health and Cancer Society of New 
Zealand, 2012). New Zealand-based research, however, has identified disassociation between 
ethnicity and skin colour following migration and inter-ethnic marriage (Callister et al., 2011). As a 
result, advocating for longer periods of sun exposure for certain ethnicities may pose an increased risk 
of skin cancer development if appropriate timeframes in which sun exposure is safer, are not identified 
(Callister et al., 2011). Dix et al. reported similar results with 83% of participants agreeing that dark-
skinned individuals needed to spend longer in the sun to synthesis vitamin D (Dix et al., 2017). 
Furthermore, Reeder et al. presented similar results, with participants reporting a longer mean 
number of minutes of sun exposure required for those with darker skin compared to lighter skin 
(Reeder et al., 2012). Neither the present study nor Dix et al. defined the UV period in which greater 
amounts of sun exposure are suitable for darker-skinned individuals. It cannot be concluded therefore, 
whether health professionals have good knowledge of safe sun exposure practices for darker-skinned 
individuals. It can be concluded however, that health professionals’ awareness of skin colour and its 
implication for cutaneous vitamin D synthesis has improved from 2010 to 2019.  
 
Health professionals in both cohorts appear confused as to whether sun exposure is safer through a 
window (see table 3.4). Similarly, health professionals appear confused about the efficacy of sun 
exposure through a window (see table 3.4). In an Australian survey of 114 mothers, 40% indicated 
sunning their baby on advice of a health practitioner to treat jaundice. Furthermore, 18.8% of these 
women indicated sunning their baby through a window (Harrison & Buettner, 1999). A further 
Australian study of 285 nurses reported that 20.5% of participants recommended sun exposure 
through a window for treatment of jaundice (Harrison, Hutton, & Nowak, 2002).  
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It is possible that a common belief about sun exposure through a window for treatment of jaundice 
has created confusion surrounding the safety and efficacy of sun exposure through a window in 
general.  
 
Awareness of living in the South Island of New Zealand as a risk factor for vitamin D deficiency greatly 
improved between 2010 and 2019 with 46.1% correctly selecting true in 2010 compared to 72.2% in 
2019. The proportion of those who selected unsure remained similar, however, with 20% selecting 
this response option in both year groups. Both the Cancer Society Position Statement on Sun Exposure 
and the Consensus Statement highlight that individuals living in more southern regions of New 
Zealand are less likely to synthesise adequate vitamin D cutaneously. A possible reason for the 
increased awareness in 2019, may follow the 2018 release of a highly publicised research article by 
Wheeler et al. that highlighted prevalent vitamin D deficiency in southern New Zealand (Wheeler et 
al., 2018). This article received media coverage by the New Zealand Herald in 2018 (Author not listed, 
2018). Dix et al. reported similar findings to the 2019 population with 76% of participants selecting 
latitude of residence as a risk factor for deficiency.  
 
Knowledge of the effects of season on vitamin D status appeared good in both year groups. In 2010, 
73.6% believed season affected the length of sun exposure needed to synthesise adequate vitamin D. 
A further 81.3% believed that vitamin D levels may fall below adequate during winter. In 2019, 
proportions were similar (87.8% and 91.1% respectively). Dix et al. found similar results with 95% of 
participants agreeing that season affects the amount of UVR exposure needed to synthesise adequate 
vitamin D (Dix et al., 2017). Reeder et al. reported that 47% of participants selected supplements as a 
primary source of vitamin D in winter, a greater proportion than those who selected sunlight, 
suggesting that health professionals in this study were also aware of seasonal impact. Furthermore, 
Reeder et al. reported that 48% of participants selected relaxation of sun protection in winter as a 
preventative measure against vitamin D deficiency (Reeder et al., 2013). Bonevski et al. reported 
however, that 33.1% of participants recommended their patients used sun protection measures at all 
times during winter. This suggests there was confusion around the impact of season of vitamin D 
synthesis. Associations between season and vitamin D deficiency have been documented in the New 
Zealand population. Lucas et al. reported that 25(OH)D levels below 50nmol/L were identified in 56-
74% of the 1606 post-menopausal participants during winter, which was an increase from the 
proportion of participants identified as having suboptimal 25(OH)D levels in summer (28-58%) (Lucas 
et al., 2005). Wheeler et al. reported that season had an effect on risk of vitamin D deficiency, in 
combination with latitude, in a prospective surveillance study of New Zealand children (Wheeler et 
al., 2015). Additionally, findings from the 2008/09 New Zealand Adult Nutrition Survey highlight that 
vitamin D deficiency is more likely to occur in the cooler months of August to October (Ministry of 
Health, 2012). It is important therefore, that health professionals are aware of the seasonal impact on 
vitamin D status.  
 
3.5.4 Awareness of Sun Exposure Guidelines for Infants and Pregnant Women 
Both year groups in the present study had opposing strengths and weaknesses regarding advice about 
sun exposure in relation to vitamin D for infants and toddlers, as neither population were able to 
unanimously identify the two key advice points in the response set. In 2010, the more frequently 
selected response was sun protection measures should be followed between 11am and 4pm (85.5%). 
This was selected by 51.2% of participants in the 2019 population however, with the more frequent 
selection being excessive sun exposure can lead to increased risk of skin cancer (84.4%). This option 
was selected by 64.8% in the 2010 population. It is concerning that near half of the 2019 population 
may not advise use of sun protection measures when discussing sun exposure in relation to vitamin 
D. More so, it is concerning that this pattern has been observed despite the increase in sun exposure 
guideline availability following 2010.  
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This finding is supported by Bonevski et al. who concluded that participants appeared more concerned 
about vitamin D status than risk of skin cancer (Bonevski et al., 2012). New Zealand has one of the 
highest rates of skin cancer internationally, secondary to a comparably harsher UVR environment 
(McKenzie, 2017). Sun exposure in relation to vitamin D adequacy therefore, must not compromise 
on sun safety behaviours, particularly in the infant population whose skin is more susceptible to UVR-
induced damage (Shafie Pour et al., 2015).  
 
Around half of the 2010 (57.8%) and 2019 (46.5%) populations believed that parents should expose 
infants to five to twenty minutes of direct sun exposure outside of the hours of 11am and 4pm, during 
summer. Sun exposure recommendations for the infant population vary, depending on the guideline 
looked at. Five to twenty minutes of direct sun exposure outside of peak UVR hours during summer is 
recommended in the Food and Nutrition Guidelines for Healthy Infants and Toddlers (Ministry of 
Health, 2008a). The current Companion Statement however, advises against direct sun exposure for 
infants at any time of the day, regardless of season (Ministry of Health, 2013a). It appears that 
knowledge of sun exposure guidelines did not improve in the 2019 cohort, with the release of the new 
guideline. A much larger proportion of the 2019 participants were unsure about the sun exposure 
guideline for infants, however. This uncertainty may be due to the conflicting guidelines in the 
Companion Statement and Food and Nutrition Guidelines for Healthy Infants and Toddlers (Ministry 
of Health, 2008a; Ministry of Health and Cancer Society of New Zealand, 2012).  Internationally, health 
professionals have been identified as an influential source of information pertaining to sun protective 
behaviours (Lin, Eder, & Weinmann, 2011). Health professionals must therefore be advocating safe 
sun exposure practices. In order to do so, guidelines available to health professionals must be 
consistent. 
 
Similar proportions of participants in both year groups agreed that infants and toddlers should spend 
time outside in the sun during winter to maintain adequate vitamin D levels (86% and 88.9% in 2010 
and 2019 respectively). For toddlers who are independently mobile, sun exposure guidelines for the 
general population are suitable and sun exposure in winter is recommended (Ministry of Health, 
2013a; Ministry of Health and Cancer Society of New Zealand, 2012). Despite season, direct sun 
exposure is not recommended for infants, however (Ministry of Health, 2013a). The specificity in 
current guidelines poses a challenge when using this question to comment on knowledge of safe sun 
exposure practices in the 2019 population. In the 2010 population, awareness of sun exposure 
guidelines was good as response mirrored the available recommendations in the Food and Nutrition 
Guidelines (Ministry of Health, 2008a). Comparison between year group relating to knowledge of safe 
sun exposure practices cannot be commented on, however, given that practices that constitute safe 
sun exposure have changed. What can be concluded however, is that these findings support those of 
a previous question from section 3.5.3, in that health professionals appear to have good knowledge 
of the influence of season on vitamin D synthesis.  
 
Just over half of health professionals in 2010 (55.4%) and in 2019 (52.2%) believed that between 
October and March, pregnant women are recommended to expose their face and arms to five to 
twenty minutes of sunshine per day. Guidelines for the general population are suitable for pregnant 
and lactating women (Ministry of Health, 2013a). For 2010 participants, it could be argued that the 
five to twenty-minute time period is in line with the Cancer Society Position statement which 
recommends a few minutes to longer, depending on skin tone, of sun exposure either side of peak 
UVR times (Cancer Society of New Zealand, 2007). Similarly, for 2019 participants it could be argued 
that the five to twenty minutes is in line with the Consensus Statement’s recommendation to partake 
in daily outdoor physical activity, the time of day at which depending on season. Furthermore, this 
recommendation is provided by the Food and Nutrition Guidelines for Healthy Pregnant and 
Breastfeeding Women.  
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This would suggest that an underwhelming proportion of health professionals had good knowledge of 
vitamin D and sun exposure guidelines. In 2010, 33.7% selected unsure in response to this 
recommendation compared to 40% in 2019. Uncertainty may be due to the lack of specificity 
regarding the time of day at which sun exposure is recommended. This question may therefore be an 
unfair representation of knowledge of safe sun exposure practices. In the following question, similar 
proportions of participants in 2010 (75.6%) and in 2019 (73.3%) disagreed that deliberate sun 
exposure during peak UVR times is recommended for pregnant and lactating women, suggesting that 
health professionals are aware of safe sun exposure practices for achieving vitamin D adequacy.   
 
Similar proportions of health professionals in both year groups believed that pregnant women would 
achieve adequate vitamin D status in summer through incidental sun exposure outside of peak UV 
hours. This proportion was close to half (53.4% in 2010 and 55.6% in 2019) suggesting that health 
professionals in this study may be uncertain about the length of time required to synthesise adequate 
vitamin D. The Food and Nutrition Guidelines highlight that incidental sun exposure in summer is 
sufficient (Ministry of Health, 2006a) suggesting that health professionals in the 2010 population were 
largely unaware of their current guidelines. The Companion Statement however does not report this, 
therefore uncertainty related to this statement in the 2019 population is reasonable. Given that there 
are many factors which impact cutaneous synthesis of vitamin D, such as skin colour, level of clothing 
and latitude, this statement may not be appropriate for achieving adequate vitamin D levels in 
pregnant women. This finding therefore appears to support results from section 3.5.3, which suggest 
health professionals have good knowledge of factors influencing cutaneous vitamin D synthesis and 
thus of risk factors for deficiency.    
 
In both year groups, participants near unanimously agreed that there was not enough information 
available to parents about vitamin D (95.2% and 94.4%). In 2013, fact sheets were published for 
parents and pregnant women by The Ministry of Health in several different languages that detailed 
sources of vitamin D, risk factors for deficiency and indicators for supplementation (Ministry of Health, 
2013b, 2013c). It is possible that health professionals in 2019 are unaware of this or do not believe it 
is adequate. As health professionals themselves are a source of information to parents, it is interesting 
that the belief of insufficient information being available to parents was so unanimous. To follow this 
up, health professionals were asked whether they felt there was enough information available to them 
regarding vitamin D. In 2010, 81.2% selected no and in 2019, 74.4% selected no. The slight decrease 
may reflect better publicity surrounding release of the new guidelines in 2012 (Ministry of Health and 
Cancer Society of New Zealand, 2012) however it is troubling that despite these specific guidelines, 
such a large proportion of health professionals in 2019 believed there is insufficient information 
available to them. Furthermore, this finding highlights that it is unreasonable to expect health 
professionals to provide adequate information to parents, if sufficient information is not available to 
the professionals themselves. This warrants further research into understanding how current clinical 
guidelines may not be meeting the needs of health professionals. These findings are supported by 
those of Bonevski et al. and Reeder at al. where majority of their participants reported that they would 
highly value clear guidelines pertaining to management of vitamin D status (Bonevski et al., 2012; 
Reeder et al., 2012). Furthermore, Bonevski et al. reported that clinical guidelines were a source of 
information for less than one third of the population (Bonevski et al., 2012). Both studies were 
conducted prior to the release of the Consensus Statement, however.  
 
3.5.5 Awareness of Supplements for Infants and Pregnant Women   
Many health professionals lacked awareness of vitamin D supplements available for infants. In 2010, 
58.4% reported being unaware and in 2019, 44.4% reported being unaware. Although awareness 
appears to have improved, it is of concern that the improvement was so slight given that PHARMAC 
opted to fund a vitamin D-only supplement for infants beginning in January of 2019 (PHARMAC, 2018).  
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Prior to this, Vitadol-C, a vitamin D-containing multivitamin, was available to infants as per the 
PHARMAC schedule (PHARMAC, 2018). Similarly, when questioned about vitamin D-containing 
supplements for pregnant women, majority of participants in 2010 (58%) and 2019 (57.8%) were 
unsure. Given that there is no vitamin D supplement designed specifically for pregnant women as 
there is for infants, and that pregnant women are advised to seek information from their health 
professional regarding supplements, it is pertinent that health professionals are aware of the options. 
Overall, health professionals appear to lack knowledge of vitamin D supplement availability for infants 
and pregnant women. The Companion Statement outlines the suitability of Vitadol C for the infant 
population as this was the funded supplement at time of publication (Ministry of Health, 2013a). An 
update is warranted given this will be discontinued and replaced with Puria (PHARMAC, 2018). 
Multivitamin and mineral supplements designed for pregnancy are not discussed in the Companion 
Statement (Ministry of Health, 2013a) which may be a potential flaw given that health professionals 
in the present study appear to lack awareness of their vitamin D content. The document does however 
highlight that the vitamin D preparation used in the New Zealand general population is suitable for 
use in pregnancy (Ministry of Health, 2013a).  
 
With different levels of detail, supplementation guidelines available to the 2010 and 2019 populations 
suggest that only infants at risk of deficiency may require vitamin D supplementation. In 2010 and in 
2019, health professionals appeared to have good knowledge of the supplementation guidelines as 
the aforementioned recommendation was the most frequently selected response when asked about 
vitamin D supplementation guidelines for infants (57.1% and 80% in 2010 and 2019 respectively). A 
smaller proportion of participants in 2019 (8.9%) were unsure about the guideline compared to 2010 
(29.8%) suggesting that awareness of this guideline improved over time.  
 
3.5.6 Knowledge of Risk Factors for Deficiency During Pregnancy and Infancy 
Overall, health professionals in 2010 and in 2019 appeared to have relatively good knowledge of risk 
factors for deficiency in pregnancy, key improvements being in acknowledgement of dark skin and 
southern locality. In 2010, the most frequently selected risk factor was covering the skin (88.8%) 
whereas in 2019, it was being housebound (94.3%). Risk factors for deficiency in pregnant women as 
per the Consensus Statement include having dark skin, being housebound, living in the South Island 
and covering the skin for cultural or religious purposes. In 2019, each of these responses were selected 
by more than 80% of participants suggesting a good level of knowledge. Furthermore, selection of 
dark skin increased from 49.2% in 2010 to 89.8% and selection of living in the South Island increased 
from 33.2% in 2010 to 78.4% suggesting that awareness of risk factors improved over the intervening 
decade.  
 
Over one third of participants selected exclusion of dairy as a risk factor (39.6% and 47.7% in 2010 and 
2019 respectively). Dairy is a source of naturally occurring vitamin D however provision of adequate 
vitamin D required to meet dietary requirements is largely dependent on food fortification (Itkonen 
et al., 2018), a practice that is voluntary in New Zealand (Food Standards Australia New Zealand, 2017). 
When sun exposure is adequate, exclusion of dairy products will not impact vitamin D status 
negatively (Ministry of Health and Cancer Society of New Zealand, 2012). It is important that health 
professionals are aware of this as to not place undue emphasis on the vitamin D content of dairy 
products before other interventions.    
 
Health professionals appeared less aware of risk factors for deficiency in the infant population. As with 
previous sections, health professionals had better knowledge of dark skin as a risk factor in 2019 
(84.3%) compared to 2010 (54.1%). In both year groups, participants appeared to have good 
knowledge of covering the skin (72.4% in 2010 and 86.5% in 2019) and irregular sun exposure as risk 
factors (89.2% in 2010 and 97.8% in 2019).  
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Participants appeared to be less aware of maternal deficiency and prematurity however frequency of 
selection increased between 2010 and 2019 suggesting an improvement in knowledge. Maternal 
deficiency is outlined as a risk factor in all available guidelines (Cancer Society of New Zealand, 2007; 
Ministry of Health, 2008a, 2013a). Prematurity, however, is outlined in the Companion Statement 
only, which may account for the increased awareness between 2010 and 2019.  
 
The proportion of participants who selected exclusive breastfeeding as a risk factor was fairly small in 
both year groups, however, did improve between 2010 (14.6%) and 2019 (32.9%). The Food and 
Nutrition guidelines state that prolonged exclusive breastfeeding is a risk factor; the Cancer Society 
Position Statement and the Companion Statement, however, specify exclusive breastfeeding without 
a timeframe. Similar findings have been observed internationally where misperception of the vitamin 
D content of breast milk led practitioners to decide against initiation of supplementation in their 
exclusively breastfed infant patients (Oberhelman et al., 2018; Sherman & Svec, 2009). While routine 
supplementation of breastfed babies is not supported by New Zealand guidelines, supplementation is 
recommended for babies who are breastfed with one or more risk factors present. Health 
professionals, therefore, must be aware of breastfeeding as a deficiency risk factor. Under-
supplementation has been observed in the New Zealand infant population despite presentation with 
risk factors for deficiency (Wheeler et al., 2015).  
 
3.5.6 Current Practices  
To explore current practices, participants were asked what advice they would give to infant or 
pregnant patients if they were concerned about vitamin D deficiency. The proportion of participants 
who indicated they did not give advice about vitamin D decreased in 2019, suggesting that health 
professionals are more active in managing vitamin D status in 2019 compared to 2010.  
 
The proportion of participants who reported they would suggest a supplement to pregnant women 
(18.9% in 2010 and 61.5% in 2019) and to infants (9.3 in 2010 to 38.8% in 2019) increased over the 
decade, suggesting increased confidence in using this treatment. These findings also highlight that 
participants may be more likely to suggest supplementation for pregnant women opposed to infants. 
This may be due to participants being unaware of supplements available for infants (table 3.6). 
Furthermore, this supports findings from the New Zealand infant population where supplementation 
has not been initiated despite presentation with risk factors for deficiency (Wheeler et al., 2015). 
Internationally, health professionals have shown greater likelihood of initiating supplementation 
when indicated in infancy (Oberhelman et al., 2018). Despite availability of New Zealand guidelines 
pertaining to supplementation with vitamin D in infants (Cancer Society of New Zealand, 2007; 
Ministry of Health, 2008a; Ministry of Health and Cancer Society of New Zealand, 2012), knowledge 
of this practice appears limited. It is not recommended that infants are exposed to direct sunlight and 
increasing food sources of the vitamin may not be appropriate depending on age and feeding mode. 
Health professionals, therefore, must be confident in prescribing supplements to the infant 
population when indicated. Nurses and Plunket Nurses make up 67.9% of the 2010 population and 
36.7% of the 2019 population. Given these professions do not typically have prescribing rights, bias 
may have been introduced to questions pertaining to supplements.  
 
The proportion of health professionals who indicated they would recommend increasing sun exposure 
for a pregnant woman increased from 51.1% in 2010 to 67.9% in 2019. It is not concerning that a large 
proportion may recommend increased sun exposure, as previous results indicate health professionals 
will advocate for this safely in pregnant women. Furthermore, this recommendation is in line with 
Best Practice Advocacy Centre New Zealand’s guideline (Best Practice Advocacy Centre New Zealand, 
2011). It could therefore be argued, that an insufficient proportion of health professionals selected 
this response. Similar proportions of participants in 2010 (51.4%) and in 2019 (62.4%) reported they 
would advise increased sun exposure for infants.  
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The proportion of participants increased between 2010 and 2019, despite release of guidelines 
advocating against direct sun exposure for infants. For independently mobile children however, sun 
exposure guidelines for the general population apply. Increasing sun exposure may therefore be a 
suitable measure. The specificity of current guidelines poses a challenge in commenting on health 
professionals’ knowledge of safe sun exposure practices for children.  
 
In both year groups, similar proportions of participants indicated they did not feel confident in their 
ability to recognise the signs and symptoms of vitamin D deficiency (84.5% in 2010 and 85.6% in 2019). 
Similar findings have been identified in existing literature. Reeder et al. reported that 43% of 
participants were not at all confident in their knowledge of vitamin D (Reeder et al., 2012). 
Furthermore, Dix et al. concluded that their results highlighted a lack of confidence amongst 
participants with regards to managing vitamin D status (Dix et al., 2017). Bonevski et al. however, 
reported that 77.3% of participants were somewhat confident in their knowledge of vitamin D. Bias 
may have been introduced into the latter study however as 43% of participants reported receiving a 
greater than usual amount of information about vitamin D in the last 12 months (Bonevski et al., 2012). 
Health professionals are at the forefront of recognising vitamin D deficiency in the general population. 
Public health becomes endangered when health professionals do not feel confident in their ability to 
recognise health conditions. Responsibility falls on both health professionals and government 
organisations to ensure members of the healthcare workforce are sufficiently equipped to manage 
health conditions. Signs and symptoms of vitamin D deficiency are outlined in the Consensus and 
Companion Statements under indications for vitamin D testing (Ministry of Health, 2013a; Ministry of 
Health and Cancer Society of New Zealand, 2012). Current New Zealand guidelines for the 
management of vitamin D status focus largely on prevention opposed to treatment however, as 
vitamin D supplementation is recommended for asymptomatic at-risk individuals. Given the limited 
focus on treatment of symptomatic deficiency, it is reasonable that health professionals do not feel 
confident in recognising the signs. Health professionals must be aware of the symptoms however, 
particularly to support the health of individuals who do not fall into the at-risk categories. Lack of 
confidence may further be explained by the number of actual or suspected cases of vitamin D 
deficiency that health professionals have been exposed to. In both year groups, over half of the 
participants reported they had encountered none over the last five years (61.2% in 2010 and 55.6% in 
2019). Of the 44.4% of the 2019 participants who had encountered or suspected vitamin D deficiency 
in a patient, 55.3% reported these cases were referred on to specialists or hospital. It cannot be 
concluded whether this is due to a lack of confidence as current guidelines advise referral to a 
specialist if metabolic bone disease is identified (Ministry of Health, 2013a). Dix et al. reported that 
participants more commonly had seen zero to five cases of vitamin D deficiency (34%) in the last year 
however 25% reported seeing 31 or more cases. Participants who had encountered over 31 cases 
were more likely to be working in private practice (Dix et al., 2017). Private practice employees were 
largely underrepresented in the present study which may account for some of the dissimilarity 
between present findings and those of Dix et al.  
 
Similar proportions of participants from both year groups expressed concern that some of their 
patients may be vitamin D deficient (68.2% in 2010 and 73.3% in 2019). Dix et al. reported similar 
results with 86% of participants indicating they were concerned that their patients were deficient in 
vitamin D (Dix et al., 2017). Further, Bonevski et al. reported that 83.3% of participants indicated they 
were concerned their patients may lack sufficient vitamin D (Bonevski et al., 2012). Reeder et al. had 
similar findings with 87% of participants indicating they were concerned their patients were not 
getting enough vitamin D (Reeder et al., 2012). Findings from the present study appear to build on 
existing literature in that concern about vitamin D deficiency is widespread amongst health 
professionals. This concern highlights that the present study was justified. Vitamin D deficiency is a 
relevant condition for the health professionals included in the present and existing studies (Bonevski 
et al., 2012; Dix et al., 2017; Reeder et al., 2012).   
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Assessing knowledge provides insight as to the care which may be provided to affected individuals, 
thus highlighting whether current clinical guidelines have been adopted into practice.  
 
3.6 Strengths and Limitations 
A key strength of this study is that it is the first, to the authors knowledge, to assess knowledge in a 
variety of health professions working with mothers and children. Existing literature focused largely on 
knowledge of GPs thus the present study had the potential to be more representative of the 
healthcare workforce compared to previous studies. Sample numbers and uneven distribution 
between health professions in the present study however, reduced representativeness. This is one of 
the first New Zealand-based studies, to the authors knowledge, which addresses health professionals’ 
knowledge after the release of the Consensus and Companion Statements, thus providing a more 
relevant assessment of knowledge. Participants were not asked whether they had seen the Consensus 
and Companion Statements; this is a key limitation in using this data to assess whether health 
professionals have incorporated the guidelines into practice. Furthermore, it reduces the reliability of 
recommendations for future practice as causation for gaps in knowledge was not addressed. Exploring 
sources of information utilised by health professionals may have alluded to the reason why knowledge 
deficits occurred. Additionally, questions developed in line with outdated guidelines may have 
confused participants in the 2019 population as recommendations differ in current guidelines, thus 
providing an inaccurate measure of knowledge.  
 
3.7 Conclusion  
Findings from the present study were largely consistent with existing literature where available. This 
study builds on existing literature suggesting that health professionals have good knowledge of 
vitamin D sources, functions and risk factors for deficiency (Bonevski et al., 2012; Dix et al., 2017; 
Reeder et al., 2012). Knowledge of sun exposure guidelines are more varied however, with some 
practices considered unsafe in line with current guidelines (Bonevski et al., 2012; Dix et al., 2017; 
Reeder et al., 2012). Gaps in knowledge appear related to the vitamin D content of breastmilk and the 
availability of vitamin D supplements for infants, despite clarification in current guidelines and recent 
release of a vitamin D-only infant supplement (Ministry of Health, 2013a; PHARMAC, 2018). Confusion 
around recommendations for sun exposure is more reasonable given the inconsistencies between 
available guidelines, particularly relating to direct sun exposure for infants (Ministry of Health, 2008a, 
2013a). Overall, knowledge appeared to improve from 2010 to 2019. Further research is necessary to 
investigate how health professionals have responded to the Consensus and Companion Statement 
and to identify effective interventions to improve knowledge in this sector of the health workforce. 
The current findings provide useful insight as to areas where further education for health professionals 




Chapter 4. Conclusion and Recommendations  
 
4.1 Overview 
The aim of this study was to assess health professionals’ knowledge and attitudes toward vitamin D 
for the general population, pregnancy and infancy. This was achieved by conducting a questionnaire 
that addressed knowledge of vitamin D status management. Additionally, this study aimed to assess 
change in knowledge, which was achieved by conducting the questionnaire in 2010 and again in 2019, 
without alteration to questions. The objectives of this study were to assess knowledge of vitamin D 
sources, functions and risk factors for deficiency, knowledge and attitudes toward sun exposure in 
relation to vitamin D adequacy, awareness of vitamin D supplements, and exploration of current 
practices regarding management of vitamin D. These objectives were achieved by development of the 
questionnaire in line with New Zealand guidelines regarding vitamin D.    
 
Health professionals in both year groups appeared to have good knowledge of vitamin D sources, 
including cutaneous synthesis as the primary source for humans and of which foods that are higher in 
vitamin D. Functions of vitamin D appeared well-known. An appropriate increase in the proportion of 
participants who believed vitamin D was involved in immune system functioning was observed from 
2010 to 2019, mirroring the increase in research available that recognises this extra-skeletal function.  
Knowledge of deficiency risk factors appeared to improve between the first and second questionnaire, 
particularly with regards to latitude and dark skin. In both year groups, the impact of season on vitamin 
D appeared well-known. With regards to infant risk factors, majority of participants in both cohorts 
failed to identify exclusive breastfeeding as a risk factor. Furthermore, a large proportion of 
participants from both year groups identified breastmilk as a good dietary source of vitamin D. 
Evidence is available that suggests breastmilk can be a good source of vitamin D if the lactating mother 
is supplemented (Hollis et al., 2015). However, health professionals should continue to identify 
exclusive breastfeeding as a risk factor for deficiency as per current New Zealand guidelines as 
breastmilk is not a naturally occurring vitamin D-rich food source (Ministry of Health, 2013a). 
Additionally, there is research available to suggest maternal vitamin D supplementation is not 
independently associated with infant 25(OH)D levels in breastfed infants (Lovell et al., 2016).  
 
Participants in 2019 appeared more aware of the impact of latitude and darker skin tone on cutaneous 
vitamin D synthesis, compared to 2010. Knowledge of the safety and efficacy of sunlight exposure 
through a window was poor in both year groups, however. Despite release of guidelines highlighting 
sunlight exposure through a window as unsafe and ineffective, knowledge did not change between 
the year groups. For infants and pregnant women, previous New Zealand guidelines discussed sun 
exposure requirements for achieving vitamin D adequacy with reference to the number of minutes 
needed to be spent in direct sunlight. The 2010 population appeared to lack knowledge of this 
guideline. Uncertainty relating to these guidelines increased in 2019, which may have been due to the 
inconsistency between recommendations outlined in the newer Consensus and Companion 
Statements (Ministry of Health, 2013a; Ministry of Health and Cancer Society of New Zealand, 2012) 
and older Food and Nutrition Guidelines (Ministry of Health, 2006a, 2008a). Newer guidelines detail 
sun exposure requirements for vitamin D adequacy with reference to participating in outdoor physical 
activity, opposed to a prescriptive number of minutes (Ministry of Health, 2006a, 2008a). Health 
professionals’ in both year groups appeared to have better knowledge of safe sun exposure practices 
for pregnant women opposed to infants. This may be due less inconsistency in sun exposure guidelines 
for pregnant women (Ministry of Health, 2006a; Ministry of Health and Cancer Society of New 




Participants appeared to have greater knowledge of the supplementation guideline for infants in 2019 
compared to 2010. Awareness of supplements available for infants however, remained poor in both 
year groups. Despite advertisement of the funded vitamin D-containing multivitamin in the 
Companion Statement (Ministry of Health, 2013a) and recent decision by PHARMAC to fund a vitamin 
D-only supplement for infants (PHARMAC, 2018), an increased awareness of infant supplement 
availability in the 2019 population was not observed. With regards to current practices in both year 
groups, a larger proportion indicated they would advise pregnant women to take a vitamin D 
supplement compared to infants, suggesting participants may lack confidence in prescribing 
supplements to infants. Participants in both year groups were largely unaware of the vitamin D 
content of supplements designed specifically for pregnant women.  
 
Current practices were addressed through selecting hypothetical advice for management of vitamin 
D deficiency in an infant or child and pregnant woman. A lesser proportion of participants indicated 
they would not give advice in 2019 compared to 2010, suggesting participants from the 2019 group 
may be more confident in managing vitamin D status. Participants in 2019 appeared to have good 
knowledge of appropriate advice for pregnant women, including increase sun exposure, increase 
intake of vitamin D food sources and to take a supplement. Health professionals in the 2019 group 
appear to have a better understanding of vitamin D management for pregnant women than for 
infants. A similar pattern was observed in the 2010 group.  
 
This study has made a valuable contribution to existing literature detailing health professionals’ 
knowledge of vitamin D. Health professionals appear to have good knowledge of vitamin D sources, 
functions and risk factors for deficiency, and this knowledge has improved over time. It appears that 
health professionals lack knowledge of safe sun exposure practices for infants, however 
inconsistencies in sun exposure guidelines for achieving vitamin D adequacy may have contributed to 
this. Overall, management of vitamin D status in infants may be an area where health professionals 
need more support, given the lack of knowledge indicated by the present study pertaining to exclusive 
breastfeeding as a risk factor for deficiency, safe sun exposure and supplement availability. Further 
research looking at sources of information utilised by health professionals may be useful in 




4.2.1 Questionnaire Design 
A key strength of this study is that, to the authors knowledge, this is the first New Zealand study to 
health professionals’ knowledge of vitamin D following an update in guidelines. Additionally, this is 
the first study, that the author is aware of, which covers such a broad scope of vitamin D knowledge. 
Previous studies focused largely on sun exposure or supplementation for infants specifically, thus the 
broad scope of this study is a major strength as overall knowledge of vitamin D can be assessed. A key 
result of this being that avenues for future research have been identified. In similar studies, knowledge 
level has been scored (AlBishi et al., 2018). The absence of a scoring system in the present study was 
a strength as this provided more specific details about health professionals’ knowledge.   
 
Another strength of this study was the use of national guidelines to devise questionnaire items. This 
provided a more objective measure of knowledge and was able to provide some insight as to whether 




4.2.2 Recruitment  
A major strength of this study was that health professionals from a range of professions, particularly 
those who are likely to work with infants and pregnant women, were recruited. To the authors 
knowledge, this is the first study in New Zealand that assesses knowledge of vitamin D in professions 
other than GPs. 
 
Use of governing bodies for questionnaire distribution is strength of this study as it increases the 
questionnaire reach and thus may increase the geographical diversity of the sample population. 
However, the two cohorts were self-selected and therefore not representative of health professionals 




4.3.1 Questionnaire Design 
A strength of this study was the use of the same questionnaire by the two cohorts. This allowed for 
accurate comparison of knowledge. A limitation of this, however, was that certain sun exposure 
questions did not align with more recent guidelines. Sun exposure questions should have been edited 
for the 2019 cohort to ensure they were in line with recommendations from the Consensus and 
Companion Statements.  
 
4.3.2 Population Characteristics  
The sample size of this study was relatively small, particularly in comparison to existing studies of 
health professionals’ knowledge of vitamin D, therefore may not be representative of knowledge in 
the wider population of health professionals in New Zealand. Furthermore, the sample size of the 
2019 year group was notably smaller than that of the 2010 year group, thus unlikely to accurately 
reflect change in knowledge. Additionally, response rate was unable to be calculated. This statistic 
may have given insight as to the sample population’s representatives of the source population.  
 
Both sample populations lacked diversity given that majority of participants were female and of New 
Zealand European ethnicity. Additionally, the 2010 year group lacked diversity between professions, 
with nurses comprising 67.9% of this year group. For both year groups, diversity amongst professions 
may have been improved if additional contact databases were used such as the Medical Council of 
New Zealand’s register of Doctors and the New Zealand College of Midwives database. GPs were 
largely underrepresented in this study; greater involvement from this profession would have 
improved diversity and therefore generalisability. It has been noted in existing literature that this 




4.4 Final Recommendations  
 
4.4.1 Key Messages from this Study  
Knowledge deficits amongst health professionals have been identified in this study. Causation for 
these deficits must be identified to strengthen interventions that focus on improving knowledge. 
Interventions to improve knowledge are likely to be well received by health professionals as near three 
quarters of all participants in both cohorts believe there is not enough information about vitamin D 
available to health professionals. Furthermore, approximately two thirds of all participants reported 
they were concerned that some of their patients may be deficient in vitamin D. Only 15% of all 
participants, however, reported they felt confident they would recognise the signs and symptoms of 
vitamin D deficiency. Areas where health professionals need further education as identified by the 
present study are:  
• The limited vitamin D content of breastmilk and recognition of exclusive breastfeeding as a 
risk factor for vitamin D deficiency.    
• Vitamin D supplements that are available to the infant population. 
• Sun exposure guidelines for infants.  
• The lack of safety and efficacy of sun exposure through a window for stimulating cutaneous 
vitamin D synthesis. 
• Recognition of the signs and symptoms of vitamin D deficiency.  
 
4.4.2 Future research  
Continuing to develop the literature regarding knowledge of vitamin D is necessary, given the 
severity of deficiency complications. Future research will be beneficial to population health as 
findings may guide development of public health initiatives. Useful avenues for future research are: 
• Assessment of where health professionals’ source their information from regarding vitamin 
D, as this may provide some understanding as to why the gaps in knowledge have occurred.  
• How best to educate health professionals, so that interventions to improve knowledge are 
successful. 
• Larger sample sizes and greater sample population diversity is needed in future studies to 
strengthen generalisability.  
• Additionally, in-depth qualitative studies are needed to better understand knowledge and 
current practices. This may highlight gaps in knowledge that cannot be identified in 
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Appendix A. Supplementary Results 
 
Table A.1 Supplementary Results  
 
 2010 n (%) 2019 n (%) 
In New Zealand we are seeing a re-emergence of rickets 
True 131 (68.2) 62 (68.9) 
False 15 (7.8) 3 (3.3) 
Unsure 46 (24.0) 25 (27.8) 
The amount of time required to be spent in the sun to allow synthesis of adequate vitamin D 
depends on the amount of skin exposed 
True 112 (58.0) 73 (81.1) 
False 42 (21.8) 9 (10.1) 
Unsure 39 (20.2) 8 (8.9) 
If yes, will pregnancy women meet their requirements for vitamin D from supplements alone? 
(In following from: Do any of the multiple vitamin and mineral supplements designed for women 
to take during pregnancy contain vitamin D?) 
Yes 13 (6.8) 4 (4.9) 
No 82 (42.7) 39 (47.6) 
Unsure 97 (50.5) 39 (47.6) 
Which of the following treatments would you use as a first line treatment for rickets? + 
Vitamin D supplements 121 (70.3) 64 (86.5) 
Calcium supplements  66 (38.4) 33 (44.6) 
Dietary change to include 
more calcium 
77 (44.8) 35 (47.3) 
Dietary change to include 
more vitamin D 
101 (58.7) 43 (58.1) 
Increased sun exposure 124 (72.1) 47 (63.5) 
Don’t know 9 (5.2) 0 
Do you ever recommend that your client/patient has a blood test to measure their vitamin D 
status? 
Yes 59 (30.6) 55 (61.1) 
No 116 (60.1) 35 (38.9) 
Not relevant 18 (9.3) 0  
Years of experience (median (25th, 75th percentile)) 
2010 (n=182) 2019 (n=86) 
15.0 (5.0, 27.5) 8.0 (4.0, 16.75) 
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B.2 Royal New Zealand Plunket Trust Application for Research & Evaluation Review 
 
ROYAL NEW ZEALAND PLUNKET TRUST 
APPLICATION FOR RESEARCH & EVALUATION REVIEW 
 
This form is for external or internal researchers seeking Plunket support for their study by way of 
advertisement, recruitment or participation. All details must be completed in full.  Please note, no 
research or evaluation funding can be allocated by the reviewers of this form. 
 
Contact Details  
 
Principal investigator: Alex Thomson ____________________________________________________ 
Organisation: Massey University _______________________________________________________ 
Role in organisation: Student Dietitian __________________________________________________ 
Email: a.thomson1@massey.ac.nz ______________  Phone: 0211623600 ____________________ 
Address: Massey University Oteha Rohe Campus, The Station Crescent, Albany, Auckland 0632 _____ 
 
Contact for this application if different from above:  
 
Name:  ____________________________________  Position:  _____________________________ 
Email: ____________________________________  Phone: 
___________________________________ 




Title: New Zealand-based Health Professionals’ Attitudes and Knowledge of Vitamin D During 
Pregnancy and Infancy _______________________________________________________________ 
Proposed start date: 1st May 2019 ______________________________________________________ 
Proposed end date: December 31st 2019 _________________________________________________ 
 
 
What support are you seeking from Plunket?  
 
I want Plunket to advertise my research/evaluation   
I want to observe, survey or interview Plunket People   
I want to observe, survey or interview Plunket Clients   
I want Plunket to help recruit participants for my research/evaluation  
Other  
Please explain ______________________________________________________________________ 
 
1. Research/ Evaluation Summary  
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Summary of purpose and objectives of the research (please use simple language, including why, 
who, what and where):  
 
The purpose of this study is to explore what New Zealand-based health professionals are 
currently recommending about vitamin D during pregnancy and infancy. Furthermore, the 
purpose of this study is to explore whether health professionals’ knowledge of vitamin D 
during pregnancy and infancy has changed within the last decade. Involvement in this study 
will require competition of a questionnaire that explores knowledge of vitamin D sources and 
functions in the body, risk factors for deficiency and supplement availability. Current practices 
regarding deficiency prevention and treatment as well as experience with cases of deficiency 
will also be explored. 
 
Vitamin D deficiency is becoming increasingly prevalent amongst infants and pregnant women 
within New Zealand. Deficiency is associated with complications of pregnancy, bone 
deformities and poor immune system functions. It is essential that prevention of vitamin D 
deficiency becomes a public health initiative. Health professionals are at the forefront of 
providing education to this population group about vitamin D and its importance for health. 
These findings will provide useful insight as to what information is being provided to pregnant 
women and the primary caregivers of infants in New Zealand. Research such as this is 
important for shaping development of public health policy that supports the health of our 
pregnant and paediatric populations. 
 
2. Risk Profile  
a) Is the Research / Evaluation testing methods, actions or advice contrary to current best 
practice guidelines? 




c) Does your research involve vulnerable participants? Yes   /   No 
 




3. Local Involvement 
a) Does your research require the involvement of a local or regional Plunket team? _ Yes   /   No  
b) If yes, where? An invitation to complete this questionnaire extends to health care staff from 
all Plunket teams nation-wide ___________________________________________________ 
c) Is the local or regional Plunket team aware of your research? _________________ Yes   /   No 
d) If yes, who have you been in contact with?  _________________________________________  
4. Reporting of results 
a) What are the expected outputs of the research?  Please include proposed publications. 
The results will be presented in a thesis as required by the Master of Science Nutrition 
and Dietetics program at Massey University, Auckland. This research is being conducted 
by student Dietitian Alex Thomson (a.thomson1@massey.ac.nz) under the supervision of 
Dr Pam von Hurst (p.r.vonhurst@massey.ac.nz) and Dr Cath Conlon 
(c.conlon@massey.ac.nz). This concludes the research team. The findings may be 
written up for publication in an academic journal if appropriate.    
 
 
b) Will the results be provided to participants? 
Yes. Questionnaire respondents are given the option of listing their email address if they 




5. Ethics  
a) Do you have ethics approval from a HDEC accredited New Zealand ethics committee? Yes   /   
No 
b) If no, will you be seeking ethics approval from an HDEC accredited ethics committee? Yes   /   
No 





How will the research be funded? No funding is required for this study.  
 
Are the proposed sources of funding likely to introduce any conflicts of interest for Plunket? 
(If unsure please put yes) Yes   /   No 
 







7. Accompanying documents 
Please attach the following to this application: 
 




• A copy of the consent form. 
• A copy of the information to be given to participants. 





• A copy of your ethics approval (if applicable)  
 
8. Signature 











Appendix C. Additional Documents  
 




I am a student Dietitian at Massey University in Auckland. 
 
I am currently completing my thesis which looks into what New Zealand-based Health Professionals 
are recommending about Vitamin D during pregnancy and infancy.  
 
I would be extremely grateful to have input from (insert relevant health 
profession/organisation/Facebook group).  
 
If you would like to be involved in this exciting research project, please follow this link and complete 
the 5-10 minute questionnaire: https://www.surveymonkey.com/r/M89VZTQ 
 
Please feel free to forward this invitation to any of your colleagues. I would love to hear from Health 
Professionals all around the country! 
 
If you are experiencing any difficulties with accessing this link, or have any questions about this 
research, please send your enquiries to me at a.thomson1@massey.ac.nz.  
 
Thank you in advance for any input you are able to provide - I know you will all be rushed off your 









C.2 Participant Information Sheet in Questionnaire Preface  
 
In this questionnaire we would like to find out about health care professionals’ knowledge of 
Vitamin D and what they are recommending to mothers and their infants and pregnant women.  
 
The questionnaire may take up to 10 minutes to complete. Try to be as honest as possible, all 
responses are confidential and anonymous. No personal details are collected which can identify you. 
We do ask about your profession and general area of work i.e. hospital, community or private 
practice but you are not required to answer these questions if you feel they could identify you or are 
uncomfortable answering them. The overall results of the questionnaire are going to presented in a 
thesis as required by the Master of Science Nutrition and Dietetics program at Massey University, 
Auckland. The findings may be written up for publication if appropriate.  
 
If you would like any further details prior to completing the questionnaire please contact either Dr 
Cath Conlon (c.conlon@massey.ac.nz), Dr Pam von Hurst (p.r.vonhurst@massey.ac.nz) or Student 
Dietitian Alex Thomson (a.thomson1@massey.ac.nz) from Massey University, New Zealand. 
 
Please note: This project has been evaluated by peer review and judged to be low risk. 
Consequently, it has not been reviewed by one of the University's Human Ethics Committees. The 
researcher(s) named in this document are responsible for the ethical conduct of this research. If you 
have any concerns about the conduct of this research that you want to raise with someone other 
than the researcher(s), please contact Professor Craig Johnson, Director - Ethics, telephone 06 
3569099 ext 85271, email humanethics@massey.ac.nz.  
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C.3 Blank Questionnaire  
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